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ABSTRACT OF THE DISSERTATION 
THE RELATION OF STEROID HORMONES AND PERSONALITY FACTORS 
TO FINANCIAL PERFORMANCE AND RISK-TAKING BEHAVIOR 
by 
Fernando M. Patterson 
Florida International University, 2014 
Miami, Florida 
Professor Robert T. Daigler, Major Professor 
This doctoral dissertation addresses the biological and psychological 
components of financial decision-making for individuals. As such, it directly 
examines intrinsic human traits that are related to financial performance, rather 
than following the standard approach of inferring said traits from aggregate 
market data. Specifically, this dissertation examines the relation of personality 
traits, testosterone levels, and cortisol levels to financial choices and outcome 
under short-term (trading) and long-term (investing) investment horizons.  
Subjects are recruited from advanced courses in finance at Florida 
International University. During the course of a semester (fourteen weeks) they 
complete a portfolio formation and rebalancing task, and answer a personality 
questionnaire. Additionally, subjects complete a series of trading simulations 
during the early morning of a preset date, and provide saliva samples. The saliva 
samples are analyzed for levels of testosterone and cortisol at a University lab 
facility. The relation of personality scores, testosterone levels, and cortisol levels 
vii 
to financial choices and outcomes is analyzed via linear regressions and 
Student’s t-tests.   
The results show that personality factors associated with detrimental life 
quality, such as paranoia, are related to long-term investment decisions 
associated with increased portfolio risk and return. Additionally, the levels of 
testosterone and cortisol play a significant role in initial portfolio formation 
decisions, but not in subsequent portfolio allocation decisions. As such, the 
results show that hormone levels contribute to initial long-term investment 
choices, but personality traits play a much greater role in portfolio maintenance.   
Alternatively, the results show that testosterone and cortisol levels play a 
significant role in many aspects of short-term investment, including the decision 
to buy or to sell, and timing preferences. Overall, the results show that hormone 
levels and personality traits play significant and distinctive roles in many aspects 
of financial decision-making. Therefore, this dissertation provides important 
implications for the practice and the study of finance, including information that 
could be used to make more rational financial choices, and to develop financial 
models with more realistic assumptions about investor behavior.    
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CHAPTER 1: INTRODUCTION 
 The traditional approach to individual financial decision-making in the 
finance literature is to deduce investor behavior from asset returns (a top-down 
approach). However, much of the individual differences among investors are 
effectively lost in this approach, because asset returns are a consequence of 
mass behavior and not individual behavior. Using this general approach, 
researchers have identified various errors in judgment, also known as behavioral 
investment biases, which are related to the overall stock market behavior. For 
example, Barber and Odean (2000) report a link between excessive market 
trading and investor overconfidence, Coval and Shumway (2005) relate T-bond 
futures market price movements and CBOT trader risk-aversion, and Locke and 
Mann (2005) find that trader success can be predicted by the relative trading 
discipline of the trader.1 Alternatively, this doctoral dissertation studies how the 
psychobiological make-up of individuals determines their financial behavior (a 
bottom-up approach). That is, I examine the role of psychological (i.e., 
personality traits) and biological (i.e., testosterone and cortisol) factors on 
financial decision-making. The advantage of this approach is that it directly 
addresses the underpinnings of investor behavior, rather than deducing investor 
behavior from aggregate market data.      
                                                            
1 Individuals who exhibit overconfidence have a confidence level in their abilities that is unjustified 
by their objective accuracy. Overconfidence generally leads to overestimating the probability of 
future success. Alternatively, risk-aversion is the tendency to prefer a certain outcome over a 
risky one when the expected payoff is the same. Risk-aversion leads to underestimating the 
probability of future success after realizing losses. Finally, trading discipline is defined as trading 
strategies that minimize behavioral biases.  
2 
 In order to truly understand how individual investor decision-making 
relates to portfolio (or market) behavior, we must start by identifying the biological 
and psychological traits related to financial decision-making. Every financial 
decision formulated by the brain has an underlying biological and psychological 
component. The decision to buy or sell, or to hedge or speculate, is the result of 
complex cerebral activity that is mediated by physiological factors, such as 
glucose (sugar) levels, hormone activity and memory, and by psychological 
factors, such as mood, stress and personality traits. Therefore, understanding the 
relation between the aforementioned factors and financial decision-making is 
necessary to understand the overall portfolio (market) behavior. This dissertation 
contributes to the developing literature by analyzing the relation of personality 
factors (Chapter 2), testosterone levels (Chapter 3) and cortisol levels (Chapter 
4) to financial decision-making.  
This dissertation has important practical implications for traders and 
investors.2 First, this dissertation shows that financial decisions and outcomes 
are related to intrinsic human factors outside of an individual’s typical conscious 
control. This knowledge can be empowering to traders and investors, especially 
because it could help them to better understand their financial decision-making 
process and to cope with poor financial performance. Second, this dissertation 
provides information that could be used by traders and investors in order to make 
                                                            
2 In this dissertation the terms “trader” and “investor” are used in reference to financial activity 
type (i.e. trading versus investing), and not to define individuals exclusively as one or the other. 
That is, a trader is anyone holding positions for relatively short periods of time (e.g. minutes, 
hours, etc.), whereas an investor is anyone holding positions for relatively long periods of time 
(e.g. months, years, etc.). 
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more rational financial decisions. Specifically, by understanding how personality 
factors and hormone levels are related to irrational choices leading to suboptimal 
investment performance, traders and investors can actively monitor their 
behavior in order to make more rational decisions. Finally, this project 
emphasizes the need for the traditional finance literature to be cognizant of the 
real factors that drive investor behavior. It is my belief that traditional models of 
finance will continue to fail until they incorporate real human behavior.   
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CHAPTER 2: THE ABNORMAL PSYCHOLOGY OF INVESTMENT 
PERFORMANCE 
2.1. Introduction 
For decades popular investment folklore has linked personality traits to 
both investing decisions and the ability to choose winners and losers. However, 
issues such as the link between personality and investment performance are 
largely unexplored areas in academic literature. In this paper I examine how 
abnormal personality traits are associated with investment performance. I derive 
my motivation to study abnormal personality traits from anecdotal reports of 
extreme behavior with institutional traders, e.g. substance abuse and sleep 
deprivation, which raises the question of whether abnormal behavior in general 
can be related to successful (or unsuccessful) investors. Unlike normal 
personality traits (such as extroversion), abnormal traits (such as depression) 
better describe the mental health characteristics of an individual. Therefore, this 
study directly examines the question of whether and how mental health 
characteristics are related to investment financial outcomes.3   
The association between underlying pathological developments in 
personality and harmful social behaviors is well documented, such as 
pathological gambling (Roy et al. 1989) and substance abuse (Tarter 1988). 
However, whether abnormal personality traits are associated with beneficial or 
harmful investment decisions has not been studied. As such, this study uses 
                                                            
3 When referring to personality characteristics, the terms “traits” and “factors” are used 
interchangeably. Similarly, the terms “abnormal personality” and “mental health” are commonly 
substituted for each other.   
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Durand et al. (2008) and Durand et al. (2010) as foundations, in that they study 
the link between Norman’s Big Five dimensions of personality (i.e., negative 
emotions, extroversion, openness to experience, agreeableness and 
conscientiousness) and investor financial choices and investment performance. 
Unlike those studies, I explore individual traits and not entire dimensions of 
personality, where the latter is composed of many traits. I also focus exclusively 
on the abnormal dimension of personality, which encompasses the disruptive 
patterns of behavior that can negatively affect investment decisions. My empirical 
investigation is also loosely related to the concepts elucidated by Gregory (2012), 
who descriptively examines the characteristics of “financial psychopaths” and 
how they can ruin lives by scamming individuals of their financial assets.  
I first determine whether individuals who pursue a formal education in 
finance possess different mental health characteristics than the typical college 
student. Such an analysis can provide hints as to the personality and social 
behaviors of individuals who ultimately become professional investors or other 
finance oriented professionals. Second, I examine whether mental health 
characteristics are related to investment performance metrics, such as the 
degree of investment diversification, the investment return, the amount of 
realized risk, and the associated risk-adjusted return. As such, I examine both 
the importance of mental health and how mental pathology (or the lack thereof) 
relates to investment performance. Finally, I determine whether women and men 
differ significantly in terms of their respective mental health characteristics 
relative to their financial performance.  
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I find that individuals who pursue a formal education in finance possess a 
different abnormal personality profile than the average college student. In 
particular, their levels of paranoia and psychopathic deviation are significantly 
above the college population mean levels. Additionally, I find that several 
abnormal personality factors are associated with the degree of portfolio 
diversification, as well as to the return, risk, and risk-adjusted return realized by 
these same individuals in their investment decisions. Consequently, the results 
show that mental health characteristics are related to both investment choices 
and financial performance.  
The results also show that the relation between mental pathology and 
investment performance is not uniform across all abnormal personality factors. In 
other words, mental pathology in most factors does not typically hinder 
investment performance. In fact, investors who exhibit mental pathology in 
several abnormal personality factors (i.e., factor scores above 8 on the 
personality test taken) significantly outperform investors with low or average 
levels of mental pathology in the overall risk-adjusted performance. I also find 
that men and women who are in the finance sample differ significantly from each 
other on certain aspects of abnormal personality, including psychopathic 
deviation and brooding discontent – areas in which men score significantly higher 
than women. Furthermore, I find that men and women exhibit both differences 
and similarities in the manner in which their mental health is related to their 
investment performance. Such differences reflect gender specific mental 
strengths and weaknesses. In other words, certain mental pathologies that affect 
7 
male investor performance do not affect female investor performance, and vice 
versa. As such, the results substantiate that benefits exist to diversifying 
investment professionals across gender.   
I add to the developing behavioral finance literature by being the first to 
demonstrate that mental health characteristics (i.e., abnormal personality traits) 
possess a statistically significant association with investment performance. 
Overall, the findings encourage the use of mental health assessment for personal 
introspection regarding finance professionals’ performance. Given the negative 
impact of irrational investment decisions on financial markets and institutions, 
such information can be of particular interest to regulators and employers looking 
to promote more rational decision-making.  
2.2. Portrayal of Investor Psychobiology in the Literature 
 Investor decision-making and their ensuing financial performance is 
influenced by many psychological factors, including intelligence, the ability to 
make rational decisions, and personality traits. In particular, the ability to act 
rationally has received substantial coverage in the literature, mainly because 
rationality is a central assumption of even the most basic theoretical models in 
economics and finance. The extent such models fail to describe market behavior 
is attributed by behavioral finance to a failure of investors to act rationally due to 
the expression of psychological biases that affect financial decision-making. In 
particular, investment biases are “affect heuristics” that result from human 
emotions, which are often at odds with human rationality. Among the most 
commonly described biases are overconfidence (Odean 1999), self-attribution 
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(Daniel et al. 1998), and the house-money effect (Thaler and Johnson 1990). 
Shefrin (2000) notes that such investment biases are highly pervasive and 
systematic. Furthermore, such biases typically result in detrimental financial 
outcomes because they promote irrational financial choices such as too much 
trading and taking unnecessary risks (see Baker and Nofsinger 2002 for a review 
of the literature on investment biases). 
 Alternatively, the errors in judgment associated with psychological biases 
should not be confused with personality traits, which are habitual patterns of 
behavior, thought and emotion. However, as with investment biases, personality 
traits are related to financial decision-making. Durand et al. (2008) show that 
several normal personality factors (such as extraversion, conscientiousness, and 
masculinity), are related to trading frequency and the proportion of shares 
invested in the market portfolio.4 Additionally, Durand et al. (2008) show that 
investor personality is related to investment outcomes, including return, realized 
risk, and risk-adjusted return. One explanation for their results is that personality 
factors help to shape financial preferences, and thereby influence the ensuing 
investment performance. In a related paper, Durand et al. (2010) show that 
personality factors are related to two investment biases, namely the availability 
heuristic and the disposition effect. Consequently, these results suggest that 
investment biases are related to personality characteristics. Therefore, it is 
                                                            
4 There are two major dimensions of personality: a normal dimension and an abnormal 
dimension. The normal dimension of personality describes human temperament and 
characteristics that are unrelated to mental health, such as extroversion, agreeableness, etc. The 
abnormal dimension of personality describes human traits that are related to mental disorders, 
such as paranoia, schizophrenia, etc. 
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possible that personality factors influence investment performance by 
predisposing investors to committing financial judgment errors.  
In addition to psychological factors, such as investment biases and 
personality traits, investor decision-making has biological underpinnings, 
including hormonal, genetic and neural correlates. For example, Coates and 
Herbert (2008) show that morning levels of the male sex hormone (testosterone) 
are predictive of daily profitability in male traders, whereas morning levels of the 
stress hormone (cortisol) are predictive of their afternoon return volatility. 
Similarly, Lo and Repin (2002) document significant changes in physiological 
variables, such as skin voltage and blood pressure, in traders during periods of 
heightened market volatility. Additional evidence of the role of investor biology in 
financial performance is provided by studies showing that medications and 
substance abuse alter financial risk-taking decisions. For example, Rogers et al. 
(2004) show that beta-blockers, which are commonly prescribed to treat high 
blood pressure, distort the perception of financial risk by decreasing the subjects’ 
ability to discriminate between large and small financial losses during a gambling 
task. On the other hand, drugs of abuse, such as marijuana and alcohol, are 
associated with a persistent preference for risky financial choices (Lane et al. 
2005).   
The latest developments in brain imaging and genetic sequencing have 
further enhanced our understanding of the biological antecedents of financial 
decision-making. For example, Kuhnen and Knutson (2005) show that the brain’s 
limbic system, which is responsible for the regulation of reward, punishment and 
10 
emotions, is differentially activated prior to pursuing risk-seeking and risk-averse 
financial choices. Additionally, this brain region is activated during impending 
irrational choices. Their findings demonstrate that risk preferences and irrational 
financial decision-making have neural antecedents. Similarly, Kuhnen and Chiao 
(2009) show that individuals with a certain genetic marker take greater financial 
risk in an investment task and have a greater susceptibility to the “framing 
investment bias” than do individuals without this genetic marker. Thus, their 
results show that financial risk-taking and investment biases also possess a 
genetic antecedent.  
Overall, investor decision-making and the ensuing investment 
performance is the result of the combined influence of psychological and 
biological factors. In fact, advances in behavioral neuroscience demonstrate that 
such factors are interrelated. For example, Cohen et al. (2005) show that the 
personality factor of extroversion has a genetic marker, and that extroversion 
scores are associated with activation of the brain’s limbic system, which 
regulates emotions. Similarly, the personality factor of neuroticism, which is 
characterized by risk-aversion, is associated with a chronic activation of the loss-
avoidance component of the limbic system (Flory et al. 2004), and has a genetic 
marker (Arnold et al. 2004). On the other hand, acute activation of the loss-
avoidance system leads to experiencing anxiety (Bechara et al. 2000), fears of 
disappointment and regret (De Martino et al. 2009), and disgust, pain and loss 
(Wright et al. 2004). These findings are consistent with abnormal personality 
factors also possessing biological markers. As such, I expect that investor mental 
11 
health plays a significant role in their financial decision-making as well as their 
ensuing financial performance in a similar fashion as their normal personality 
traits.  
2.3. Method 
2.3.1. Participants 
 A total of 221 finance students participated in an investment-personality 
study composed of 97 female (43.9%) and 124 male participants (56.1%). The 
study was restricted to graduate (n=19) and undergraduate (n=202) students 
enrolled in an investments course, with the majority of subjects (n=184; 83.3%) 
enrolled in an advanced security analysis course. Consequently, such subjects 
possessed a greater sophistication in finance and investments than the general 
population.  
2.3.2. Procedure 
Participants engaged in a thirteen-week investment task in which they 
controlled $50,000 in paper money to invest freely in any kind of financial 
instrument, including cash. At the end of each week the participants determined 
their total portfolio value. The price for each trade was determined based on the 
close value on the day of trade submission. Trades and weekly portfolio values 
were checked for accuracy. During their trading activity the participants were 
encouraged to employ investment advice and news releases, as well as to 
research their investment vehicles. Their grade in the course was affected by up 
to one full grade by their overall risk-adjusted performance, using the S&P500 
12 
index as the benchmark.5 Therefore, allocating a large amount of money to 
poorly performing or highly volatile assets could result in poor performance.  
In addition to the investment task, participants completed a personality 
test that measures both normal and abnormal aspects of personality. Only those 
who volunteered to complete the questionnaire are included in this study; over 
95% of the total number of individuals completed the questionnaire.6  
2.3.3. Investment Performance Measures 
I employ the validated investment results to measure each individual’s 
portfolio diversification, risk, return and risk-adjusted return. Since common stock 
is essentially the only investment in the portfolios (as stock represents 99% of all 
investments), I employ the Standard & Poor’s 500 index (S&P 500) as a proxy for 
the market portfolio. The weekly portfolio values are converted into twelve weekly 
portfolio excess returns using the concurrent three-month T-bill risk-free rate. 
Appendix A describes the typical performance measures employed for the 
analysis. 
2.3.4. Abnormal Personality Measures 
 I employ the Clinical Analysis Questionnaire (CAQ) developed by 
Raymond Cattell to assess the abnormal personality profile of participants. The 
CAQ is a 272-item personality test that measures sixteen primary factors of 
normal personality (Part I), and twelve primary factors of abnormal personality 
                                                            
5 The final grade was adjusted upward (downward) by 1% for each 1% the portfolio outperformed 
(underperformed) the S&P500. The adjustment for graduate students was 0.5%, since their grade 
distribution was more condensed.  
 
6 The participants knew all information would be analyzed anonymously. Furthermore, there were 
no consequences for declining to participate in the study. 
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(Part II). Each personality factor is measured via twelve test items, and each item 
employs a 3-point Likert response scale of agree, disagree, and sometimes 
agree. Raw factor scores are converted into standard ten (sten) scores using 
standardization tables that reflect individual differences in age and gender.7 Sten 
scores rather than total scores are employed in the data analysis. Sten scores 
range from a minimum of 1 to a maximum of 10 in the majority of factors, and 
have a standardized mean of 5.5 and a standard deviation of 2 in the population. 
For all twelve abnormal factors measured in Part II, a sten score of 1 reflects an 
absence of mental pathology, whereas increasingly higher sten scores are 
associated with an increasingly greater degree of mental pathology. Appendix B 
provides summary descriptions of each abnormal factor. Table 2.1 shows the 
correlation matrix between the abnormal factors. These correlations show to 
what extent the factors are related. Since few correlations exceed 0.60 and none 
are 0.70 or above, there are no serious correlation issues among the factors.8 
2.3.5. Data Analysis 
Since the population mean (5.5) and its variance (2) for all abnormal 
factors is determined by the 16PF construction, I employ the Student’s t-test to 
                                                            
7 Four standardization tables are provided in the CAQ Manual for converting raw scores to 
standard (sten) scores, namely, conversion tables for college male and female populations 
(based on age 20), and norms for general adult male and female populations (based on age 30). 
The tables were developed via a non-linear transformation that normalizes the sten scores so that 
the resulting mean and standard deviation are 5.5 and 2, respectively.  
 
8 Mental health characteristics seldom exhibit high comorbidity (comorbidity is the simultaneous 
presence of two or more medical conditions, whether or not they typically coexist for an 
individual). The 16 PF is constructed using a factor analysis approach to find (relatively) 
independent psychological factors. Therefore, I consider the correlation between the abnormal 
personality factors to be indicative of comorbidity but not necessarily associated with true 
multicollinearity of related factors. The correlations in Table 2.1 do not approach the 0.9 
correlations typically associated with troublesome multicollinarity.  
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compare participants’ factor scores to their population averages. On the other 
hand, male and female factor scores are compared via the Welch-Satterthwaite t-
test, which does not assume equal variances.9 Furthermore, I crosscheck the 
results for all t-tests with their nonparametric equivalent Wilcoxon signed-rank 
test, which does not make assumptions concerning the distribution of the factor 
scores. 
I analyze the relation between investor mental health and his/her 
investment performance by employing stepwise regressions using the backward 
elimination procedure, where each performance measure is originally regressed 
on all twelve abnormal personality factors.10 In order to capture any gender 
differences, I perform the analysis for the entire sample as well as for the female 
and male subsamples separately. Since the objective is to determine whether a 
relation exists between investor mental health and his/her investment 
performance as well as the form of such a relation, I do not make any 
assumptions concerning the components or exact nature of this relation.11  
                                                            
9 An appropriate personality factor comparison between males and females is made possible by 
the use of sten scores. Unlike total scores, in which men and women exhibit natural differences, 
sten scores are derived from total scores after accounting for the gender differences. For 
example, a total score of 13 on psychopathic deviation (factor Pp) translates into a sten score of 5 
in a female college student and a sten score of 4 in a male college student, since male college 
students naturally possess higher total scores in factor Pp than female college students.  
 
10 The objective of the backward elimination procedure is to find a linear model that best explains 
the investment performance metric using the abnormal personality factors. Initially, F-statistics 
are computed for all of the abnormal personality factors. The factor with the p-value that most 
exceeds the specified critical p-value (10%) is then removed from the model. The procedure is 
repeated until no p-values exceeding the critical p-value remain in the model.  
 
11 The lack of literature on this subject also limits us from formulating specific hypotheses about 
the relation between abnormal personality factors and investment performance. In the results 
section I discuss the intuition behind the observed results.   
15 
Regression analysis helps us to understand the general linear relation 
between investor abnormal psychology factor scores and his/her investment 
performance. However, it does not tell us how extreme personality abnormalities 
are related to investment performance. Therefore, I also analyze the relation 
between abnormal personality factors and investor performance without the 
restrictive assumptions of linear regression analysis. Specifically, I compare the 
investment performance of investors with low factor scores (scores of 1-3), 
average factor scores (scores of 4-7), and high factor scores (scores of 8-10) 
using the Welch-Satterthwaite t-tests and Wilcoxon signed-rank tests. These 
demarcations are the same ones employed by healthcare professionals. 
Therefore, they allow us to meaningfully compare the investment performance of 
healthy, normal, and psychologically abnormal investors. 
2.4. Results 
2.4.1. Investment Performance 
Investor performance is summarized in Table 2.2. The mean and median 
R-squared values show that investors’ portfolios are 59% to 67% as diversified 
as the market portfolio. However, there is substantial variation in portfolio 
diversification within the sample, which shows that investors have heterogeneous 
diversification preferences. Similarly, the variation in portfolio beta and return 
volatility shows that the sample of investors has heterogeneous risk preferences. 
On average, investors realized economically significant excess returns (average 
excess returns, alpha), regardless of the degree to which they diversified their 
portfolios. However, the measures of risk-adjusted return have a substantial 
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variation within the sample, showing that some investors realized losses when 
greater risk was undertaken. Specifically, 31.7% of investors realized negative 
Sharpe ratios during a down-market, whereas 5.88% of investors realized 
negative Sharpe ratios during an up-market. 
2.4.2. Investor Abnormal Personality 
Table 2.3 displays the abnormal personality results of the CAQ test for the 
sample of college students. Figure 2.1 provides a visual representation of the 
average abnormal personality profile, as well as the associated 25th and 75th 
percentiles of the profile across the sample. Compared to the population average 
factor score of 5.5, the sample exhibits significantly different scores for all but the 
brooding discontent factor (D3). In particular, the sample exhibits the largest 
positive differences for the paranoia factor (Pa) and the psychopathic deviation 
factor (Pp). This means that individuals pursuing a finance education possess a 
lower tendency to trust others and a higher tendency to break the rules than the 
average college student. The high incidence of psychopathic deviations in 
finance students is consistent with the discussion of financial psychopaths on 
Wall Street by Gregory (2012). In particular, the results showing that many of 
those in the finance field have some aspects of psychopathic tendencies is 
consistent with individuals possessing such traits before entering the field, rather 
than developing such traits as a result of the profession’s “culture.”   
The sample used here also exhibits lower than average levels of mental 
pathology for many factors, including the majority of depression variants (the D 
factors), schizophrenia (Sc), compulsivity (As) and psychosis (Ps). These factors 
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have a less intuitive relation to financial decision-making, and have more to do 
with overall wellbeing. In fact, high scores on these factors typically have 
crippling life-style effects on individuals. Therefore, it is not surprising that the 
sample exhibits relatively “healthy” scores for such factors. Most importantly, the 
results show that individuals who pursue a career in finance exhibit a mental 
health profile that is different on a statistically significant basis relative to the 
general population of college students. In particular, such individuals display 
mental stability across many factors that are necessary for proper daily 
functioning, as well as characteristics typically associated with risk-taking, such 
as low levels of trust and a greater tendency toward engaging in illegal acts or 
breaking of the rules. 
2.4.3. Mental Pathology and Investment Performance  
 Table 2.4 displays the average performance for investors with “low”, 
“average,” and “high” scores on abnormal personality factors. These 
demarcations are used to identify an individuals’ mental pathology level (such as 
low, average and high mental pathology, respectively). Overall, the results show 
that investors in the different abnormal personality groups exhibit significant 
differences in every measure of investment performance. For example, investors 
who are enthusiastic and energetic (i.e., low D5), as well as relaxed, 
considerable and cheerful with people (i.e., low D7) diversify their portfolios to a 
lesser degree than investors with average scores on such factors. On the other 
hand, investors who realistically appraise themselves and others, and show an 
absence of regressive behavior (i.e., low Sc) diversify their portfolios to a greater 
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degree than investors who retreat from reality and have uncontrolled and sudden 
impulses (i.e., high Sc). These results provide the first line of evidence that 
mental illness hinders the desire, ability or will to diversify an investment 
portfolio.12 
The measures of return (i.e., AVE, HPR and Alpha) show that either low, 
average or high levels of specific mental pathologies can be associated with the 
highest and lowest levels of profitability, depending on the factor in question. For 
example, investors with average levels of anxious depression (D4) achieve a 
larger holding period return than investors with low levels of anxious depression, 
as well as achieving a larger average return than investors with either low or high 
levels of anxious depression. On the other hand, investors with low levels of 
bored withdrawal (D7) and hypochondriasis (D1), achieve larger returns than 
investors with average pathology levels on such factors. Finally, investors with 
high levels of psychopathic deviation (Pp) achieve a larger holding period return 
than investors with average levels of psychopathic deviation.  
 The relation between investor mental health and financial risk-taking is 
also not straightforward. For example, investors with high levels of both 
hypochondriasis (D1) and guilt and resentment (D6), experience significantly 
lower volatility in their returns than investors with average and low levels of 
pathology on these factors. Similarly, investors with high levels of schizophrenia 
(Sc) have lower betas compared to investors with low levels of schizophrenia. On 
the other hand, investors with low levels of compulsivity (As) and suicidal disgust 
                                                            
12 Regressive behavior means to revert to an old, usually immature behavior. 
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(D2) experience higher return volatility and portfolio betas, respectively, 
compared to investors with average and high levels of pathology on such factors. 
Finally, investors with high levels of paranoia (Pa) and psychopathic deviation 
(Pp) experience greater return volatility than investors with low pathology on 
these factors.13 
 In terms of risk-adjusted investment performance, the results show that 
some dimensions of mental pathology are detrimental to investment 
performance, whereas others appear to enhance performance. For example, 
investors with low levels of pathology on bored withdrawal (D7) and 
schizophrenia (Sc) exhibit greater Sharpe ratios than individuals with average 
scores on such factors. Alternatively, investors with average scores on anxious 
depression (D4) outperform investors with low levels of anxious depression on a 
risk-adjusted basis (i.e., using the Sharpe ratio). Interestingly, psychopathic 
deviation is the one factor where both low and high scoring investors outperform 
their average scoring investors. Therefore, the overall conclusion from the results 
is that high levels of mental pathology are not necessarily related to inferior risk-
adjusted performance. In fact, in certain cases it might lead to better return for 
the risk undertaken.  
 
 
                                                            
13 Paranoia and schizophrenia are likely to be linked to greater financial risk-taking via their 
association with sensation seeking (Blackburn 1969). Zuckerman (1979 and 1994) finds that 
sensation seeking is associated with participation in a number of risky activities, reckless driving 
and drug abuse. Furthermore, Horvath and Zuckerman (1993) find that high sensation seekers 
tend to appraise risk lower than do low sensation seekers. 
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2.4.4. Abnormal Personality and Investment Performance 
In this section I examine the overall relation between abnormal personality 
factor scores and investment performance measures in a fashion similar to 
Durand et al. (2010). The analysis employs the entire range of factor scores (i.e., 
1 to 10) in a linear regression model by using the backward elimination 
procedure for regression.14 The regression results displayed in Table 2.5 show 
that investment performance and the degree of portfolio diversification is related 
to an individual’s mental health. In particular, investor scores on hypochondriasis 
(D1) and low energy depression (D5) relate to the diversification measure of the 
portfolio R-squared. In this regard, the less the concern for bodily functions, 
illness and disability and the more they feel worried and weary, the more likely 
they are to diversify their portfolios. These results provide a partial explanation 
for why many studies, such as Barber and Odean (2000), find that retail investors 
hold portfolios concentrated in only a few stocks. In other words, in addition to 
cognitive abilities (Korniotis and Kumar 2008), financial sophistication and 
behavioral biases (Goetzmann and Kumar 2008), and investor resourcefulness 
(Ivkovich et al. 2008), I show that mental health is another explanatory variable 
for portfolio diversification preferences. Moreover, I do not find that investor trust 
levels (i.e., paranoia) are associated with the degree of portfolio diversification, 
which seems to contradict Guiso et al. (2008) who find that individuals with a 
general lack of trust have a limited participation in the stock market. The data are 
                                                            
14 I opt not to run regressions based on personality factor groupings (such as low, normal and 
high scores) since such comparisons are already addressed by the univariate analysis presented 
in the previous section. 
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examined via the White test, showing no violation of homoscedasticity for this 
table, or other relevant tables. 
Regarding portfolio risk, the results show that greater levels of paranoia 
(Pa) are related to greater return volatility and portfolio beta, which means that 
investors who are less trusting of others take greater financial risks. These 
results are consistent with studies that find paranoia to be related to risky social 
behaviors, including pathological gambling (Graham and Lowenfeld 1986), risky 
sexual behaviors, and drug use (Elifson et al. 2006). The results add to the 
literature by showing that paranoia is also related to financial risk-taking. 
Similarly, I find that investors who are zestful (i.e., a lower score on factor D2), 
experience greater worrying (i.e., a higher score on factor D5), and realistically 
appraise themselves (i.e., a lower score on factor Sc), create portfolios with 
higher betas. In fact, the scores on factors Pa, D2, D5, and Sc together explain 
about 5% of the total variation in portfolio beta.  
Lastly, the results show that paranoia and psychopathic deviation are 
related to the Treynor index of beta-adjusted returns. In general, investors who 
are more paranoid and less psychopathically deviant exhibit greater risk-adjusted 
performance, as measured via the Treynor index. Interestingly, these are the 
same two factors in which the sample of college students score significantly 
above the population mean. As such, paranoia and psychopathic deviation seem 
to play a role in selecting a career in finance as well as during financial decision-
making.     
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The results shown in this section offer a different perspective than those 
by Durand et al. (2010). In particular, I identify the particular personality factors 
associated with the Big Five personality dimensions as I relate them to 
investment performance, as well as identify other traits not covered by the Five 
Factor Model. Widiger and Mullins-Sweatt (2009) provide a table where they 
relate several abnormal personality traits to the Big Five personality dimensions. 
Using this table it is possible to compare some of my results to Durand et al. 
(2010). In particular, I show that energy depression (D5) is positively related to 
portfolio diversification and beta risk, which is consistent with Durand et al. 
(2010) who show that negative emotions, which includes depression as one of its 
traits, is positively related to portfolio diversification and beta. I also find that traits 
not covered by the “Big Five” are related to measures of investment performance 
that are similar to those in Durand et al. (2010), as well as vice-versa; such 
results show that that neither the personality inventory examined here or the Big 
Five used in Durand et al. (2010) fully captures the link between investor 
personality and his/her financial performance.  
2.4.5. Gender, Abnormal Personality, and Investment Performance 
The use of abnormal personality factor sten scores instead of total scores 
allows us to compare male and female subjects, with the sten scores accounting 
for the natural gender differences inherent in abnormal personality. In terms of 
investment performance, I find that that men exhibit significantly greater portfolio 
return volatility than women (the results are available upon request). Otherwise, 
men and women diversify their portfolios to a similar extent, as well as achieve 
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similar gross and risk-adjusted returns. These results negate the common 
misperception than men are better investors than women. On the other hand, the 
results do show that men experience greater return volatility than women, which 
is consistent with other studies on gender differences and risk-taking preferences 
(e.g., Eckel and Grossman 2002). Furthermore, as the results in Table 2.6 show, 
men have higher brooding discontent (D3) and psychopathic deviation (Pp) 
scores than women, which is consistent with their differences in risk-taking. 
Moreover, men possess a higher degree of uncontrolled and sudden impulses 
(Sc). In other words, men seeking careers in finance seek excitement, are 
restless, take risks, try new things, engage in illegal acts or breaking rules, 
possess less impulse control, and exhibit anti-social behavior to a greater extent 
than their female counterparts.  
A visual representation of the average male and female personality profile 
is shown in Figure 2. Even though noticeable differences exist, the figure shows 
that men and women seeking careers in finance still share more similarities than 
differences in their mental health profile. However, this does not mean that the 
manner in which mental health and financial performance are related is the same 
for men and for women. In fact, the results displayed in Table 2.7 show that the 
factors associated with a particular investment performance measure in men are 
not necessarily the same factors for women. For example, greater levels of 
hypochondriasis (D1) are associated with lower portfolio diversification for men. 
Conversely, whereas women score significantly higher in the hypochondriasis 
factor than men, their hypochondriasis scores are unrelated to financial 
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performance. Similarly, a greater level of paranoia (Pa) in women is associated 
with greater portfolio volatility (SD), whereas men’s levels of paranoia are 
unrelated to their investment performance.  
2.5. Conclusions 
In this study I analyze the relation between investor mental health and 
his/her investment performance. As such, the results provide clues concerning 
the mental health characteristics of individuals who are likely to seek a career in 
the investment area of finance, as well as the link between their investment 
success and personality factors. I find that these individuals exhibit significantly 
higher levels of paranoia and psychopathic deviation than the average person. 
This supports the ad hoc supposition that such abnormal personality factors are 
higher in the finance profession than in the general population. Furthermore, I 
show that abnormal personality factors are related to portfolio diversification, 
realized risk, return, and risk-adjusted return.  
The results have implications for finance practitioners. Investors interested 
in understanding and improving their financial performance should not neglect 
the effects of their abnormal personality traits to their financial performance. In 
fact, research shows that investors who are highly self-monitoring perform better 
than their peers (Biais et al. 2002). As such, self-monitoring of our own abnormal 
psychology can lead to improved financial performance. 
Future studies could compare different kinds of finance professionals, 
such as traders, managers and analysts, to determine differences in their mental 
health characteristics. Those results could then be compared to mines to 
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determine the personality characteristics of those who are ultimately successful 
in the finance industry. In addition to career choice, mental health characteristics 
could also be related to investment preferences, styles, and the social behaviors 
of finance professionals. As such, future studies could address whether the 
social behaviors of investment professionals are related to their financial 
decision-making.  
Finally, I leave it to future studies to address the precise mechanism by 
which mental health is related to financial outcome. For example, studies could 
address whether the perception of financial risk and the propensity to commit 
investment biases are related to mental health characteristics. Durand et al. 
(2010) find an association between normal personality traits and investment 
biases. Therefore, it is worth exploring whether a similar relation exists between 
investment biases and abnormal personality traits. This line of research has clear 
implications for practitioners. Additionally, it can serve to enhance our current 
understanding of investor financial decisions and the behavioral models that rely 
on them. 
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Table 2.1 
Abnormal Personality Factor Correlation Matrix 
This table shows the correlation coefficients between the twelve abnormal 
personality factors in the sample (n=221). 
 D1 D2 D3 D4 D5 D6 D7 Pa Pp Sc As Ps
D1 1.00 0.52 -0.14 0.51 0.68 0.57 0.48 0.37 -0.39 0.43 0.39 0.54
D2 0.52 1.00 -0.02 0.34 0.58 0.56 0.48 0.43 -0.30 0.54 0.35 0.47
D3 -0.14 -0.02 1.00 -0.26 -0.12 -0.23 -0.11 0.05 0.50 0.03 -0.13 -0.20
D4 0.51 0.34 -0.26 1.00 0.47 0.46 0.33 0.20 -0.46 0.32 0.46 0.53
D5 0.68 0.58 -0.12 0.47 1.00 0.54 0.51 0.35 -0.36 0.49 0.38 0.54
D6 0.57 0.56 -0.23 0.46 0.54 1.00 0.48 0.36 -0.42 0.43 0.56 0.47
D7 0.48 0.48 -0.11 0.33 0.51 0.48 1.00 0.39 -0.22 0.45 0.33 0.50
Pa 0.37 0.43 0.05 0.20 0.35 0.36 0.39 1.00 -0.08 0.65 0.41 0.41
Pp -0.39 -0.30 0.50 -0.46 -0.36 -0.42 -0.22 -0.08 1.00 -0.20 -0.33 -0.41
Sc 0.43 0.54 0.03 0.32 0.49 0.43 0.45 0.65 -0.20 1.00 0.46 0.50
As 0.39 0.35 -0.13 0.46 0.38 0.56 0.33 0.41 -0.33 0.46 1.00 0.37
Ps 0.54 0.47 -0.20 0.53 0.54 0.47 0.50 0.41 -0.41 0.50 0.37 1.00
Notes: Appendix B provides descriptions of the personality factors. For this 
sample size, a correlation coefficient greater than 0.11 or less than -0.11 is 
regarded as statistically significant. 
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Table 2.2 
Investor Performance Summary Statistics 
This table displays the summary statistics for portfolio performance for the entire 
sample (n=221). The table shows the abbreviation (Label) used for each 
performance measure, the sample mean, median, minimum (Min), maximum 
(Max) and standard deviation (St. Dev) of the scores for  each performance 
measure.   
Performance measure Label Mean Median Min Max St. Dev
Portfolio diversification PDIV 0.5912 0.6675 0.0000 0.9766 0.2664
Average excess return AVE 0.1279 0.0955 -0.8388 2.5594 0.4866
Holding period return HPR 0.1017 0.0809 -0.8562 2.4896 0.4701
St. Dev of returns SD 0.2099 0.1744 0.0040 0.7844 0.1243
Sharpe ratio Sharpe 1.2919 0.5700 -0.6104 12.0320 1.8246
Portfolio alpha Alpha 0.0473 0.0210 -0.7460 1.8877 0.2939
Portfolio beta Beta 0.8184 0.7954 -2.7596 3.2306 0.4945
Treynor ratio Treynor 0.6844 0.1148 -6.4140 101.3602 6.8644
Notes: Appendix A describes how each performance measure is computed.  
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Table 2.3 
Investor Abnormal Personality Summary Statistics  
This table displays the mean and standard deviation (St. Dev) of personality 
factor scores for the entire sample (n=221). The twelve abnormal personality 
factors are measured via Part II of Cattell’s Clinical Analysis Questionnaire. The 
factors are described in Appendix B. The sample mean scores are compared to 
the college student population mean scores of 5.5 via the Student’s t-test. The 
resultant one-tail p-value is shown in the last column. 
Personality factor Mean St. Dev p-value (1 tail)
D1*** 4.66 2.13 <0.0001
D2*** 4.47 1.64 <0.0001
D3 5.63 2.27 0.2000
D4*** 4.91 1.86 <0.0001
D5*** 4.52 1.92 <0.0001
D6*** 4.84 1.94 <0.0001
D7*** 5.00 1.91 0.0001
Pa*** 5.81 1.94 0.0085
Pp*** 6.30 2.10 <0.0001
Sc*** 4.72 1.90 <0.0001
As*** 5.17 2.07 0.0089
Ps*** 4.78 1.51 <0.0001
Notes: Significant differences are given next to the factor label in terms of 10% 
(*), 5% (**) and 1% (***) levels.  All t-test results for mean differences were 
consistent with the results obtained from the non-parametric Wilcoxon signed-
ranked tests for median differences.  
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Table 2.4 
High, Average and Low Factor Scores and Investment Performance 
This table shows the average performance of investors with low (1-3), average 
(4-7) and high (8-10) abnormal personality factor sten scores in the columns 
under “Mean performance.” The sample size is displayed in parenthesis under 
the average performance values. P-values for significant differences between low 
(L), average (A) and high (H) scoring investors are displayed in the next three 
columns, under “p-value (1 tail).” Only p-values with a significance level below 
10% are displayed. First, the groups were tested for equality of variance using 
the F-test with a 5% significance level. Then, groups with statistically equal 
variances were tested for mean differences using the pooled two-sample t-test. 
Alternatively, groups with statistically different variances were tested for mean 
differences using the Welch-Satterthwaite two-sample t-test. The Welch-
Satterthwaite p-values are displayed in italics, whereas the pooled p-values are 
displayed in normal type. 
  Mean Performance p-value (1 tail) 
Factor Measure Low sten Ave sten High sten L vs A A vs H L vs H 
D1 SD 0.2192 
(72) 
0.2101 
(129) 
0.1750 
(20) 
 0.0629 0.0717 
D2 Beta 0.8734 
(86) 
0.7966 
(126) 
0.5989 
(9) 
  0.0174 
D3 Alpha -0.0428 
(37) 
0.0571 
(137) 
0.0895 
(47) 
0.0134  0.0167 
D4 AVE 0.0339 
(52) 
0.1749 
(147) 
0.0362 
(22) 
0.0399 0.0584  
D4 HPR 0.0203 
(52) 
0.1428 
(147) 
0.0199 
(22) 
0.0574   
D4 Sharpe 1.0275 
(52) 
1.3966 
(147) 
1.2170 
(22) 
0.0709   
D4 Alpha -0.0136 
(52) 
0.0696 
(147) 
0.0424 
(22) 
0.0431   
D5 PDIV 0.5318 
(68) 
0.6187 
(135) 
0.6096 
(18) 
0.0153   
D5 SD 0.1973 
(68) 
0.2221 
(135) 
0.1661 
(18) 
0.0940 0.0336  
D5 Beta 0.7531 
(68) 
0.8615 
(135) 
0.7418 
(18) 
0.0948 0.0729  
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Table 2.4 – Continuation  
  Mean Performance p-value (1 tail) 
Factor Measure Low sten Ave sten High sten L vs A A vs H L vs H 
D6 SD 0.2256 
(59) 
0.2102 
(141) 
0.1641 
(21) 
 0.0106 0.0062 
D7 PDIV 0.5509 
(52) 
0.6122 
(149) 
0.5394 
(20) 
0.0764   
D7 AVE 0.2398 
(52) 
0.0909 
(149) 
0.1122 
(20) 
0.0321   
D7 HPR 0.2124 
(52) 
0.0605 
(149) 
0.1208 
(20) 
0.0248   
D7 Sharpe 1.6718 
(52) 
1.1748 
(149) 
0.1870 
(20) 
0.0783   
Pa SD 0.1471 
(27) 
0.2181 
(151) 
0.2207 
(43) 
0.0001  0.0005 
Pa Beta 0.6795 
(27) 
0.8231 
(151) 
0.8890 
(43) 
0.0432  0.0320 
Pp HPR 0.1664 
(22) 
0.0596 
(129) 
0.1591 
(70) 
 0.0981  
Pp SD 0.1842 
(22) 
0.2081 
(129) 
0.2212 
(70) 
  0.0536 
Pp Sharpe 1.6482 
(22) 
1.1062 
(129) 
1.5220 
(70) 
0.0784 0.0793  
Pp Alpha 0.0703 
(22) 
0.0204 
(129) 
0.0895 
(70) 
 0.0745  
Pp Treynor 4.9112 
(22) 
0.1310 
(129) 
0.3758 
(70) 
 0.0408  
Sc PDIV 0.6243 
(59) 
0.5869 
(150) 
0.4821 
(12) 
  0.0327 
Sc SD 0.1839 
(59) 
0.2215 
(150) 
0.1924 
(12) 
0.0257   
Sc Sharpe 1.6587 
(59) 
1.1606 
(150) 
1.1290 
(12) 
0.0391   
Sc Beta 0.8548 
(59) 
0.8164 
(150) 
0.6648 
(12) 
  0.0541 
As SD 0.2295 
(50) 
0.1989 
(130) 
0.2208 
(41) 
0.0959   
Notes: Appendix A provides descriptions of the performance measures and 
Appendix B provides descriptions of the abnormal personality factors. 
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Table 2.5 
Linear Relation between Factor Scores and Investment Performance 
This table shows the regression results using the stepwise backward elimination 
procedure, where the dependent variable is one of the portfolio performance 
measures (columns) and the independent variables are the twelve abnormal 
personality factors (rows). Only the measures with a significant relation to 
abnormal personality factors after the stepwise backward elimination regression 
results are displayed. Homoskedasticity of the error terms is verified using the 
White test, which tests the null hypothesis that the variance of the residuals is 
homogeneous. 
Independent  
variable PDIV SD Beta Treynor
D1 **-0.0254  
D2 *-0.0503 
D3  
D4  
D5 **0.0274 *0.0412 
D6 **-0.0098  
D7  
Pa **0.0106 **0.0566 *0.4586
Pp  **-0.5087
Sc **-0.0520 
As  
Ps  
Summary stats  
R2 2.57% 3.28% 5.13% 4.40%
Notes: The significance of the regression coefficients is displayed next to the 
coefficients by employing the following asterisks: significant at the 10% (*), 5% 
(**), and 1% (***) levels. Also shown is the regression R-squared value under the 
“Summary stats” label. Appendices A and B provide descriptions of the 
performance measures and the abnormal personality factors, respectively. 
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Table 2.6 
Male and Female Subject Abnormal Personality Summary Statistics 
This table displays the mean and standard deviation (St. Dev) of the abnormal 
personality factor scores of the male (n=124) and female (n=97) subjects in the 
sample. Mean differences in the male and female scores are tested using the 
two-sample Student t-test. The one tail p-value is shown in the last column. 
 Males Females 
Personality factor Mean St. Dev Mean St. Dev p-value (1 tail)
D1** 4.42 2.04 4.96 2.21 0.0307
D2 4.59 1.58 4.32 1.72 0.1141
D3*** 6.05 2.26 5.09 2.18 0.0009
D4 4.92 1.81 4.91 1.93 0.4809
D5 4.56 1.89 4.46 1.97 0.3619
D6 4.76 2.00 4.94 1.88 0.2479
D7 5.00 1.94 5.01 1.87 0.4842
Pa 5.88 1.87 5.73 2.04 0.2888
Pp** 6.57 2.00 5.95 2.18 0.0140
Sc* 4.87 1.77 4.53 2.05 0.0907
As 5.08 2.10 5.28 2.04 0.2412
Ps 4.80 1.51 4.75 1.53 0.4120
Notes: Significant differences in the mean scores are given next to the factor 
label in terms of the 10% (*), 5% (**) and 1% (***) levels. See Appendix B for a 
description of the factors. All t-test results for the mean differences are consistent 
with the results obtained from the non-parametric Wilcoxon signed-ranked tests 
for median differences.  
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Table 2.7 
Relation between Abnormal Personality Factors and Investment Performance in Women versus Men 
This table shows the regression results using the stepwise backward elimination procedure for significant variables only. 
The dependent variable is one of the portfolio performance metrics and the independent variables are the twelve 
abnormal personality factors for the sample of female (n=97) and male (n=124) participants. 
 Women  Men 
Independent 
variables PDIV AVE SD Sharpe Alpha Treynor PDIV Sharpe Beta
D1    **-0.0325
D2  *-0.0610    **0.2517 ***-0.0964
D3  *0.0227   
D4    
D5     ***0.0522   **0.0755
D6   **0.0710 **-0.0148  
D7    
Pa   ***0.0140  *0.8774 
Pp   *-0.9259 
Sc **-0.0295   *-0.2042
As  *0.0274 **-0.0598 *-0.1782 **-0.0327  
Ps    
Summary 
stats 
   
R2   7.61%   8.30%    9.43%   3.55%    3.08%    8.03%    8.01%   4.28%    6.64%
Notes: Appendices A and B provide descriptions of the performance measures and the abnormal personality factors, 
respectively. The homoskedasticity of the error terms was verified using the White test, which tests the null hypothesis 
that the variance of the residuals is homogenous.  The significance of the regression coefficients is displayed at the 10% 
(*), 5% (**), and 1% (***) levels next to the coefficient. Also shown is the regression R-squared value under the “Summary 
stats.” 
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Figure 2.1 
Plot of Abnormal Factor Scores Percentiles of the Sample 
This figure displays the 25th, 50th (i.e. the mean), and 75th percentile of the sten 
scores for the twelve abnormal personality factors. The sample size is 221. The 
gradient (non-jagged) line represents the college student population mean scores 
of 5.5. Table 2.3 provides the numerical values for the sample mean scores and 
standard deviations of the 50th percentile results. Appendix B describes the 
personality factors.  
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Figure 2.2 
Plot of Male and Female Mean Abnormal Personality Factor Scores 
This figure displays the average male (n=124) and female (n=97) abnormal 
personality factor scores. The gradient (non-jagged) line represents the college 
student population mean scores of 5.5. Table 2.6 provides the male and female 
mean and standard deviation scores. Appendix B provides descriptions of the 
personality factors.  
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CHAPTER 3: TESTOSTERONE AND FINANCIAL CHOICES 
3.1. Introduction 
 This essay deals with the effect of the sex hormone testosterone on 
financial decision making. A large body of research (summarized below) 
demonstrates that testosterone plays a key role in decisions involving economic 
risk and reward. In particular, testosterone is thought to exert a significant 
influence on the cognitive processes that deal with the interpretation of financial 
information, risk preferences, and investor confidence (Coates et al. 2010). 
Therefore, the testosterone level can have important repercussions on our 
financial decisions and the resulting investment outcomes. However, the nature 
of this role is not well understood. For example, it is not known whether 
testosterone influences every kind of financial choice (such as long-term 
investing versus high-frequency trading), or if its effect is limited to a particular 
subset of financial tasks. Additionally, the behavioral mechanism of testosterone 
affecting financial decision making, including its effect on risk perception and 
cognitive biases leading to irrational choices, is poorly understood.  
 Understanding the role of testosterone in financial decision making is 
important for several reasons. First, individual investors could benefit from being 
aware of the role of testosterone on their financial choices. By actively monitoring 
their testosterone levels, individual investors could maintain testosterone levels 
within a range that is considered optimal for decision making — such as a range 
associated with a greater number of rational decisions, a lower exposure to 
unnecessary risk, and higher profitability. Second, institutional investors, such as 
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large corporations and investment funds, could benefit from having their traders 
consider the role of testosterone in financial decision making and its effect on 
ensuing outcomes. Third, financial markets and market regulators would benefit 
from an increased number of responsible investors who actively manage the 
influence of testosterone on their financial choices.  
 In this essay, I investigate the role of testosterone on financial choices and 
outcomes during a portfolio formation (asset allocation) task and an options 
trading task. The tasks involve financial decision making for long term investment 
and high frequency trading. Thus, this essay examines whether decision 
“frequency,” which is high during the options trading task, and low during the 
portfolio formation task, determines whether testosterone is related to financial 
decision making. Given that males have approximately 20 times more circulating 
testosterone than females do; this study also investigates the important issue of 
gender differences in the relation of testosterone with financial decision making. 
Finally, this essay analyzes the behavioral influence of testosterone on financial 
decision making by examining whether levels of testosterone affect asset 
allocation choices or are associated with costly financial behavior, such as 
excessive trading.  
3.2. Literature Review 
 Only a few studies have addressed the effect of testosterone on financial 
decision making, leaving much to be explored. Three important issues that 
remain poorly understood are: 1) how does testosterone affect financial 
outcomes (such as investment risk and return)? 2) Is testosterone related to 
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different types of financial decisions (such as decisions concerning trading 
versus decisions involving investing)? And 3) what is the behavioral mechanism 
by which testosterone influences financial decisions? The reminder of this 
section describes the extent to which these three questions are addressed in the 
literature to date.  
 Literature on the relation of testosterone to financial decision making is 
concentrated in a few recent studies. Coates and Herbert (2008) and Coates et 
al. (2009) find evidence for a correlation of testosterone levels with financial 
decision making. Coates and Herbert measured morning (11:00 a.m.) and 
afternoon (4:00 p.m.) testosterone levels in a small group (n=17) of male traders 
for eight consecutive business days under real working conditions. The authors 
find that traders achieve a significantly greater daily profitability (profit and loss 
level, or P&L) on days when their morning testosterone level is above their 
overall median level over the course of the study. These results indicate that 
morning testosterone levels can partially predict the direction of daily profitability 
in traders. Similarly, Coates, et al. (2009) measure the second digit to fourth digit 
finger ratio (2D:4D) of 44 high frequency male traders and find it to be predictive 
of the traders’ P&L levels over a 20-month period. The 2D:4D ratio is directly 
related to the amount of in-utero testosterone exposure. Therefore, the results 
suggest that prenatal testosterone level is associated to the long-term profitability 
of high-frequency traders.  
 The Coates and Herbert (2008) and Coates et al. (2009) studies show 
evidence that testosterone is related to financial profitability, providing a partial 
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answer to the question of how testosterone affects financial outcomes. However, 
they do not find that a relation exists between testosterone and financial risk 
taking. This finding (or rather lack thereof) is curious, given the empirical 
evidence linking testosterone to a variety of social behaviors involving risk, such 
as a higher likelihood of committing a violent crime among male prison inmates 
(Dabbs et al. 1987), drug use, aggressive violence and high-risk sexual behavior 
among anabolic steroid users (Middleman and DuRant 1996), and antisocial and 
deviant behavior among male U.S. Army veterans (Mazur 1995). Nevertheless, 
the medical literature shows that monetary incentives are processed by different 
brain areas than other kinds of rewards (Knutson et al. 2001). Therefore, the 
results in Coates and Herbert (2008) and in Coates et al. (2009) support the view 
that financial risk taking is not related to testosterone levels due to the unique 
way in which the brain perceives and responds to financial risk.  
 Apicella et al. (2008) investigate the link between testosterone and 
financial risk preferences in men. Participants are asked to bet any desired 
amount of money from an original $250 endowment in a coin-toss gamble. A 
winning toss returns 2.5 times the amount wagered, whereas a losing toss 
forfeits the amount of the bet. The authors show that salivary testosterone level 
(Sal-T) is positively correlated with the amount bet in the gamble. As such, the 
results show that endogenous testosterone levels are related to financial risk 
preferences in men. In contrast, Sapienza et al. (2009) measure risk aversion 
using the algorithm from Holt and Laury (2002), in a task where subjects make 
choices between a risky lottery and varying certainty equivalents that provides a 
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guaranteed return.15 They find that salivary testosterone is associated with lower 
risk aversion among women, but not among men. As such, Apicella et al. (2008) 
and Sapienza et al. (2009) provide conflicting results as to whether a relation 
between testosterone levels and risk aversion actually exists. However, their 
conflicting results could be due to the way that each study measured risk 
aversion, which is notoriously difficult to do.  
 Studies in which participants are administered testosterone exogenously 
(i.e. orally or intravenously) also have yielded inconsistent results. Van Honk et 
al. (2004) show that women who are given exogenous testosterone exhibit 
decreased risk aversion during the Iowa Gambling Task (IGT). These results are 
consistent with Stanton et al. (2011), who show that endogenous testosterone 
levels are positively associated with risk taking in the IGT among men and 
women. Alternatively, Goudriaan et al. (2010) fail to show that men with supra-
physiological levels of testosterone perform differently in the IGT. Similarly, 
Zethraeus et al. (2009), using a version of Holt and Laury’s (2002) algorithm, fail 
to show that testosterone administration in women is associated with financial 
risk preferences. Therefore, similar to the studies analyzing the relation between 
endogenous levels of testosterone and financial risk taking (discussed in the 
previous paragraph), studies using exogenous measures of testosterone fail to 
provide consistent results. 
                                                            
15 Holt and Laury (2002)’s algorithm is a method to measure the degree of risk aversion. Subjects 
are presented with a menu of paired lottery choices which are structured so that the crossover 
point to the high-risk lottery can be employed to infer the level of risk aversion.  
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 Stanton et al. (2011) propose that the inconsistent results from studies 
examining the relation between testosterone and economic risk are due to the 
nonlinear effect of testosterone on economic risk. In particular, they show that 
endogenous testosterone levels have a U-shaped association with financial risk 
preference and ambiguity preference, but not with loss aversion.16 Thus, both 
men and women with intermediate levels of testosterone were found to be risk 
and ambiguity averse, whereas those with low and high testosterone were found 
to be risk and ambiguity neutral. However, the inconsistent results found 
throughout the literature could also be due to the fact that studies use a variety of 
different tasks to measure economic risk, use either laboratory or real-life 
settings, measure either endogenous or exogenously manipulated levels of 
testosterone, and include either one or both genders. Consequently, the U-
shaped financial risk versus ambiguity relation is as yet unproven.  
 Because of the difficulties associated with replicating real-life economic 
incentives in the laboratory, several studies prefer to examine investor behavior 
in their natural environment. However, the nature of the financial task itself can 
be the explanation of why studies of this kind (e.g., Coates and Herbert 2008; 
Coates et al. 2009), do not find that testosterone level is related to financial risk 
taking in professional traders. Which brings us to the next question: Is 
testosterone related to all types of financial tasks (i.e., both trading and investing 
                                                            
16 Ambiguity preference describes the preference towards known risks and unknown risks. As 
such, an ambiguity averse individual prefers known risk situations over unknown risks situations. 
Importantly, ambiguity describes situations where outcome probabilities are unknown. 
Alternatively, risk aversion describes situations where outcome probabilities are known (see 
Epstein 1999).  
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or short-term and long-term)? Coates and Herbert (2008) and Coates et al. 
(2009) use a sample of traders, whom by definition engage in very short-term 
financial decisions. At this level of decision making, factors other than 
testosterone can play a larger role in the risk undertaken by individuals. In fact, 
Coates and Herbert (2008) find that the stress hormone cortisol is linked to the 
volatility of the traders’ P&L levels and the volatility of the market, which shows 
that stress level plays a larger role than testosterone in the risk-taking behavior of 
traders. Alternatively, the time pressure that pervades high-frequency trading is 
present to a much lesser degree in other kinds of financial tasks, such as long-
term investment planning and decision-making games like the IGT. Thus, we can 
intuitively link the pressure to quickly produce results during high-frequency 
trading to high stress, which could outweigh the influence of testosterone on risk 
taking during trading.  
 Finally, only a few studies examine the question of how testosterone 
levels influence financial decision making. This is perhaps the most difficult 
question to answer, because it involves understanding the biochemical 
mechanism of testosterone action in the brain. In general, testosterone is thought 
to influence financial decision making by shifting economic utility functions, 
confidence levels, and/or risk preferences, through its effect on the brain’s 
nucleus accumbens. As a part of the dopamine system, the nucleus accumbens 
is associated with pleasure as well as irrational, risk-seeking behavior (Kuhnen 
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and Knutson 2005).17 Evidence of the “rewarding” property of testosterone is also 
found in addiction studies of humans taking anabolic steroids (Kashkin and 
Kleber 1989).18 Biologists have also found that male primates (including humans) 
experience elevated levels of testosterone during situations of physical 
challenge. For example, athletes show increased testosterone levels during 
competition, and testosterone levels increase further after winning an event 
(Gladue et al. 1989). Therefore, testosterone appears to play a major role in 
winning and losing contests.  
3.3. Methods19 
 This study follows a similar methodology as other studies on the relation of 
endogenous testosterone levels to economic behavior. That is, subjects provide 
demographic information as well as a saliva sample that is used to measure their 
level of testosterone. After subjects provide the saliva sample, they engage in 
three financial tasks using a trading and investment simulation software. Finally, 
their level of testosterone is related to their financial performance and risk-taking 
behavior via statistical analysis.    
 
                                                            
17 Dopamine is the major neurotransmitter of the reward system of the brain, which includes the 
ventral tegmental area, the nucleus accumbens, the amygdala, the hippocampus, and the medial 
prefrontal cortex. Rewarding experiences such as food, sex, and drugs lead to the release of 
dopamine, providing feelings of enjoyment and motivating the reinforcement of these activities. 
Bressan and Crippa (2005) provide a basic review of the dopamine system and its role in reward 
and pleasure.  
 
18 This rewarding property is thought to be due to the effects of testosterone and its two metabolic 
byproducts (dihydrotestosterone (DHT) and estradiol) on the nucleus accumbens, causing an 
increase in dopamine release (Frye et al. 2002).  
 
19 Prior to conducting the study, Institutional Review Board (IRB) approval was obtained from 
Florida International University’s Office of Research (Protocol Approval #IRB-13-003). 
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3.3.1. Subject Recruitment and Preparation  
 In order to employ participants who possess a superior knowledge base in 
finance (as compared to the average person) subjects were recruited from 
graduate students in Florida International University’s financial software course, 
in which they learn to use the financial trading simulation application Rotman 
Interactive Trader 2.0 (RIT 2.0).20  Forty-eight students agreed to participate in 
the study and signed consent forms.21 The sample is composed of 14 women 
(31%) and 31 men (69%).22  
 In order to ensure that participants were proficient users of RIT 2.0, the 
trial was scheduled at the end of the course, when participants had had sufficient 
experience with RIT 2.0. (After the trial, participants were asked to rate their level 
of comfort using RIT 2.0, on a scale of 1 (lowest comfort) to 5 (highest comfort). 
The median response score is 4, showing that most participants had a high 
degree of comfort).  
 Participants were given access to the simulation case descriptions 
employed in the study on the course website several weeks prior to the trial. 
Therefore, participants who were interested in performing well in the trial 
                                                            
20 The simulation software was developed at the BMO Financial Group Finance Research and 
Trading Lab (the Rotman Finance Lab) at the University of Toronto’s Joseph L. Rotman School of 
Management). With the permission of the instructor, study participants were recruited during the 
second week of the course. Potential participants were then provided a general description of the 
study and told what was expected of them, including that they would be expected to provide 
saliva samples. However, participants did not know what was being tested for in the saliva. 
 
21 Subjects were asked to provide data regarding their age, gender, and ethnicity (one subject 
withheld the age data.) Three subjects subsequently dropped out, leaving a final trial sample 
comprised of 45 subjects (a participation rate of 94%).  
 
22 Participants were from several ethnic backgrounds, including Asian (33%), Black (7%), 
Hispanic (44%) and White (16%), and they ranged in age from 22 to 50, with a median age of 25 
at the time of the study.  
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prepared by reading the cases and using the accompanying Excel spreadsheet 
to understand the cases in advance. In a post-trial questionnaire participants 
were asked to rate their preparation for the trial on a scale of 1 (lowest) to 5 
(highest). The median score is 4, showing that most participants believed they 
achieved a high degree of preparation for the trial. Additionally, 34 (76%) 
participants reported using the Excel spreadsheet to prepare for the portfolio 
formation task.23 
3.3.2. The Trial 
 One week before the trial, participants were given a printout with detailed 
preparation instructions. This same handout was posted to the Blackboard Learn 
online course interface. Since testosterone follows a circadian rhythm, with the 
highest levels exhibited during the morning hours, the trial was conducted in the 
morning.  
 Participants were instructed to arrive at the computer lab facility by 8:15 
a.m. on the day of the trial, and to refrain from eating or drinking anything after 
8:00 a.m. on that day, in order to provide a clean saliva sample. The trial began 
at 8:20 a.m. and lasted for one hour. Saliva samples were collected immediately 
before the trial, using a standard procedure.24 After the trial, the saliva samples 
                                                            
23 During the week before the trial, participants were reminded via an online announcement to 
review the study instructions and simulation cases, and they were asked to take a short online 
questionnaire to test their knowledge about the instructions and the simulation cases. Thus, every 
measure was taken to ensure that participants knew in advance what to expect during the trial. 
By the day of the trial, 37 (77%) participants had completed the online questionnaire. The median 
score is 5 (out of 6 questions), showing that the majority of participants were very familiar with the 
trial instructions and the simulation cases 
 
24 The procedure can be summarized as follows: Each subject was provided with a Salivette® test 
tube at the time of collection. All subjects were given sugar-free gum in order to stimulate saliva 
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were transported to a Florida International University lab facility, were the salivary 
testosterone (Sal-T) levels were measured via mass spectrometric analysis.25   
3.3.3. The Investment Simulations 
 Immediately following the collection of the saliva sample, participants 
engaged in three financial tasks using RIT 2.0.26 The first two tasks involve 
investment decision-making (i.e., long-term financial choices), whereas the third 
task involves trading decision-making (i.e., short-term financial choices). The 
investment tasks are identical to each other, and they are identified as 
“Diversification” by Rotman. Henceforth these tasks are referred to as the 
Diversification 1 (DIV1) and Diversification 2 (DIV2) tasks, whereby the number 
provides the order in which the tasks were performed – that is, DIV1 is the first 
task of the trial, whereas DIV2 is the second task of the trial.  
                                                                                                                                                                                 
production. Subjects produced a minimum sample of 3 ml of saliva, which they inserted into the 
test tube. The test tubes were sealed and refrigerated within 48–72 hours of collection at –20°C 
until analysis. The timespan between saliva collection and refrigeration does not influence 
hormonal concentration, as saliva can last up to five days on average before it degrades. 
  
25 The procedure for mass spectrometric analysis can be summarized as follows: To 1000 µL of 
saliva add both methanol Internal standard (Testosterone D3) 1 ng; Cortisol-D4 2 ng/100 µL.  The 
samples are mixed with 4 ml of ethyl acetate, agitated for 15 minutes, and then centrifuged at 
3000 rpm for 10 minutes. After the aqueous layer is frozen, the ethyl acetate layer is isolated. The 
solution is evaporated using a centrifugation evaporator. The extract is dissolved in 100 µL of 70 
% acetonitrile, and 10 µL of this solution is injected into the LC/MS/MS system. A parallel solid 
phase extraction (SPE) process using 1 ml 30 mg HLB cartridges is used instead of organic 
extraction. Here 1000 µL of the saliva sample is used, fortified with the corresponding internal 
standard and centrifuged at 3000 rpm. The supernatant is subject to SPE analysis using a mix of 
water and methanol, and the final methanolic extract is evaporated and reconstituted in the 
mobile phase for further mass spectrometric analysis. Simultaneous Testosterone, Testosterone-
D3, Cortisol and Cortisol Dd4 are determined using selective reaction monitoring (SRM) of the 
following transitions (m/z):  289.3 → 97.3, 292.3→97.3, 363.3→327.1, and 367.3→331.3, 
respectively.  For quantification purposes, at least five levels of calibration are use in the pg/µL 
range, using an internal standard. 
 
26 The cases were developed by the Rotman Finance Lab to be used with the RIT simulation 
software. Case descriptions are available for download from at the Lab’s website for subscribers. 
Additionally, instructors have access to the case solutions and to the master Excel spreadsheets 
that allow each case to be tailored as needed.  
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 During the investment tasks subjects have an endowment of $500,000 to 
invest in a portfolio of assets that must grow to $1.5 million by the end of the 
simulated time horizon (i.e., 20 years). The subjects can choose from five 
Electronic Trading Funds (ETFs) of different historical returns and volatilities 
(shown in Table 3.1). After making their allocation choices in the ETFs (or in 
CASH for funds not invested), each of the ETF prices evolve as a random walk 
with positive drift and standard deviation, as given by their historical return and 
volatility. As such, the price paths can be significantly different between DIV1 and 
DIV2. The investigator did not manipulate the price path of any security. Although 
DIV1 and DIV2 are identical, they are not considered so from a financial 
decision-making perspective. This is because naïve investors typically allow their 
recent past performance to influence their subsequent investment choices. Since 
DIV1 is immediately followed by DIV2, DIV1 is regarded as an initial portfolio 
creation task, whereas DIV2 is regarded as a portfolio rebalancing task.   
 The third task of the trial is an options trading simulation, involving four 
options contracts on the same non-dividend paying stock. The stock is not 
tradable, but its price is observable. The price of the stock follows a stochastic 
pre-generated path over the duration of the case. The options can be purchased 
or sold via limit or market orders.    
3.3.4. Testosterone Measurement 
 Free (unbound) saliva testosterone (Sal-T) measurement is the preferred 
method to study circulating levels of testosterone in the body because of to the 
noninvasiveness of the procedure used to collect the saliva. However, unlike 
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blood analysis, there is no standard way to measure the Sal-T concentration. 
Therefore, benchmarking is constrained by the particular procedure used to 
determine the concentration of Sal-T. In other words, it is difficult to compare 
absolute levels of Sal-T across studies because of the different methodologies 
used to test for concentration. Therefore, I let the sample statistics dictate what 
constitutes high, intermediate, and low levels of Sal-T in subjects. 
 Another aspect of testosterone measurement to consider is the fact that 
testosterone, being the primary male sex hormone, is many times higher in 
males than in females. In this sample, the mean Sal-T concentration was 30.0 
pg/mL (SD=17.0) in men and 7.4 pg/mL (SD=9.1) in women.27 Due to the natural 
gender difference in testosterone level, I converted individual raw Sal-T levels to 
z-scores relative to the Sal-T distribution for the gender of the individual. This 
technique is employed by other studies that use a sample of mixed genders (e.g., 
Mehta et al. 2008). The z-scores are used for all the analyses.  
3.4. Investment Performance Results 
3.4.1. Asset Allocation Choices 
 Table 3.1 shows the average asset allocation choices of subjects during 
each task. The results show that subjects give HOME and GROW, which are the 
two most volatile assets, approximately equal average weighs during both tasks. 
In fact, there is no significant difference between HOME and GROW investment 
proportions within each task. This shows that subjects regard HOME and GROW 
                                                            
27 Stanton et al. (2011) obtains mean salivary testosterone levels of 86.5 pg/mL (SD=26.0) for 
men and 14.2 pg/mL (SD=7.0) for women. These levels are very different from the ones in this 
study, illustrating the difficulties in benchmarking Sal-T using different protocols and results from 
other studies.  
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as equivalent securities, despite GROW having almost twice the volatility as 
HOME. Combined, the proportions invested in HOME and GROW account for 
almost half the total allowance, showing that subjects value “risker” assets more 
than they value safer ones. A similar phenomenon is apparent between BOND 
and MINE. Despite having twice the volatility, the proportion of funds allocated to 
MINE is not significantly different from that allocated to BOND during both tasks. 
This result shows that subjects likely consider BOND and MINE to be relatively 
“similar” securities. 
 The smallest proportion of funds was allocated to MMKT during DIV1 and 
DIV2. Surprisingly, a considerable proportion of funds was left uninvested (kept 
as CASH), especially during DIV1. The redistribution of CASH into the four riskier 
assets during DIV2 demonstrates that investors learned from their prior task 
performance. The fact that subjects still prefer to keep some funds as CASH 
during DIV2 instead of investing it in MMKT demonstrates a certain level of 
irrational risk aversion. The reason that allocating to CASH instead of MMKT is 
irrational is because their historical volatility is essentially equivalent whereas 
CASH provides no return and MMKT provides a 2% return. 
3.4.2. Investment Return and Volatility 
 After subjects allocate their allowance (partially or fully) across the five 
ETFs, the price of each instrument evolves over a simulated period of 20 years. 
The price path is randomly selected for each ETF based on a normal mean-
distribution equal to the ETF’s historical return and a standard deviation equal to 
the ETF’s historical volatility. Monte Carlo simulations of 2,000 iterations were 
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performed for each subject in order to calculate the expected portfolio return, 
volatility and shortfall.28 Table 3.2 shows the portfolios’ expected and realized 
return and volatility during DIV1 and DIV2.  
 Table 3.2 shows that expected portfolio return is significantly larger for 
DIV2, but the realized return underwent a significant drop. These results are 
similar to what transpires in real life investments – investments do not always live 
up to their expectations. The table also shows a significant increase in portfolio 
volatility (both expected and realized) during DIV2, which is consistent with an 
allocation into riskier securities, as seen in Table 3.1  
 Subjects had an investment goal of (at least) $1.5 million by the end of 20 
years. Since their initial allowance was $500,000, their goal was to achieve a 
return of 200% over the 20 years, or an annual return of 5.65%. Given that the 
average annual return during DIV1 far exceeded the required annual return, the 
combined results of Table 3.1 and Table 3.2 show that subjects in the sample 
take greater risks than needed to meet their investment goal. These results also 
illustrate that investors are return-oriented rather than goal-oriented. In other 
words, after outperforming their objectives in DIV1, subjects choose to increase 
                                                            
28 Subjects were able to run the Monte Carlo simulations on their own before the trial if they 
desired. The Monte Carlo simulations were based on 2,000 iterations, meaning that the resulting 
return and volatility were the average of 2,000 different possibilities for the combined portfolio of 
assets. Therefore, the results of the Monte Carlo simulation very closely approximate the 
expected return that could be computed using the weights and the historical returns of the 
securities. Aside from the Monte Carlo simulations, subjects had no other way to compute a 
numerical value for the expected portfolio volatility, because the numerical correlations between 
the securities were only known to the researcher.  
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their risk further in DIV2, even though with greater risk comes a greater chance 
of falling short of achieving the minimum required $1.5 million portfolio value.29  
3.4.3. Investment Performance 
 The chance of not achieving the required investment goal (e.g., the 
percentage shortfall) can be computed via Monte Carlo simulation. The average 
percentage shortfall for DIV1 and DIV2 is shown in Table 3.3. The table also 
shows additional measures of risk and return associated with the allocation 
choices of subjects, including the Sharpe ratio (the ratio of excess return to 
volatility), the final portfolio value, the total return (over 20 years), the abnormal 
return (the realized return in excess of the expected return), and the value at risk 
(VaR, the maximum expected loss in one year for a 95% confidence level).  
The results in Table 3.3 are consistent with the increased risk undertaken 
during DIV2, as shown in Table 3.2. In particular, the maximum size of yearly 
losses (VaR) is higher for DIV2. Additionally, although the chance of not meeting 
the investment objective of $1.5 million in 20 years (shortfall) is lower during 
DIV2, this is due to a much lower proportion of funds left uninvested  in Cash 
during DIV2. Funds not invested achieve a zero return, whereas funds invested 
in the MMKT security achieve 2% return on average — neither choice comes 
close to the 5.65% annual return necessary to meet the investment goal. 
                                                            
29 It is possible that some subjects had goals surpassing the 5.65% benchmark. This is not unlike 
what transpires in real life. Investment managers have been known to take much larger risks than 
instructed by their clients. However, this does not take away from the fact that by taking more 
risk, they could also realize greater losses, and therefore fail to meet their client’s demands. 
Additionally, subjects were told that risk-adjusted performance, and not gross performance, was 
the measure of success.      
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Therefore, as the proportion of funds either not invested or invested in MMKT 
decreases during DIV2, so does the shortfall.   
 Consistent with the greater risk undertaken during DIV2, Table 3.3 shows 
that the average DIV2 portfolio is expected to generate greater final wealth, total 
return, and abnormal return than the average DIV1 portfolio. However, the 
significant differences between DIV1 and DIV2 portfolio composition and 
expected performance show that investor choices during DIV2 are partly 
influenced by the allocation choices and the portfolio performance during DIV1. 
However, as asset managers frequently caution, recent past performance is not 
a predictor of future performance, and ultimately, the realized performance during 
DIV2 is significantly lower than the realized performance during DIV1. Thus, 
subjects should not have let the realized performance from DIV1 influence their 
portfolio formation decisions for DIV2, because the return process for each 
security is independently identically distributed (i.i.d.).  
 Table 3.3 also shows that predicted Sharpe ratios for DIV2 are statistically 
lower than those of DIV1. Therefore, the additional risk undertaken during DIV2 
does not result in superior risk-adjusted returns relative to DIV1. The difference in 
Shape ratios demonstrates that differences in portfolio efficiency could exist 
between DIV1 and DIV2. In other words, on average the portfolios formed during 
one of the tasks could lay further away from the efficient frontier than portfolios 
formed during the other task.  
 Appendix C provides a detailed discussion of portfolio efficiency in relation 
to DIV1 and DIV2. Overall, the results show that there is no difference in portfolio 
53 
efficiency between DIV1 and DIV2. As such, the results show that investors do 
not actually learn to allocate funds more efficiently during DIV2 after observing 
their performance for DIV1. Rather, the obvious link between DIV1 performance 
and DIV2 allocation choices appears to have more to do with being return-
oriented rather than goal-oriented — which could be related to the “rewarding” 
properties of testosterone, as shown in the literature.  
3.5 Testosterone and Investment Decisions and Outcome 
3.5.1. Testosterone and Asset Allocation Decisions 
 The literature reviewed in Section 3.2 shows that some research finds the 
relation between testosterone and economic decision to be linear and other 
research finds it to be quadratic. Consequently, in this research two regression 
models are used in order to capture the potential appropriate relation, namely 
linear (Model 1) and/or quadratic (Model 2). A third model (Model 3) adds the 
gender of investors as a dummy variable (Females=0, Males=1) to capture 
gender differences not accounted for by the role of testosterone. Lastly, a fourth 
model (Model 4) is performed on DIV2 variables in order to capture the influence 
of the performance during DIV1.  
 Table 3.4 displays the significant relation between salivary testosterone 
(Sal-T) and asset allocation during DIV1 (Panel A) and DIV2 (Panel B). Since the 
results in Table 3.1 show that subjects view certain securities as being “similar,” 
the relation of testosterone to fund allocation is also examined for the combined 
high-risk securities (HOME and GROW), medium-risk securities (BOND and 
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MINE), and low-risk securities (MMKT and CASH) — although CASH is 
technically not a security and is also risk-free.  
 Table 3.4, Panel A shows that the predominant relation between Sal-T 
and the initial asset allocation decisions (DIV1) is linear in nature. Specifically, a 
negative relation exists between Sal-T and the proportion of funds allocated to 
High Risk securities, including GROW, whereas a positive relation exists 
between Sal-T and the proportion of funds allocated to the Low Risk securities. 
Thus, the results show that testosterone possesses a negative linear relation to 
risk taking during the initial allocation decisions in investment tasks. These 
results are incongruent with studies that report a positive relation between 
testosterone levels and risk-taking (e.g., Apicella et al. 2008), studies that report 
a negative relation between testosterone levels and risk-aversion (e.g., Sapienze 
et al. 2009), and studies that report a quadratic relation between testosterone 
levels and economic risk-aversion (e.g., Stanton et al. 2011). However, these 
studies rely on economic games, such as the IGT, to evaluate investor risk 
preferences. In contrast, the investment scenario in this study is very realistic, as 
individuals are often required to allocate funds to their own retirement portfolios 
using similar investment instruments and information (such as the historical 
return and volatility of the securities). Furthermore, it is unlikely that individuals 
have similar risk preferences for gambles as they do for their retirement choices. 
Thus, individuals are unlikely to make financial decisions about how to balance 
their investment portfolios the same way they make gambling choices in Las 
Vegas during a weekend getaway.   
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Table 3.4 also shows that during portfolio rebalancing the Panel B 
testosterone levels are related to the allocation of funds into securities with 
intermediate risk levels (i.e., MINE and BOND), showing a shift from DIV1 risk 
preferences. Additionally, the results show that nonspecific gender differences 
(i.e., gender differences not related to levels of testosterone), and the memory of 
recent past performance, shape the nature of the relation between testosterone 
and reallocation choices. Specifically, high and low testosterone subjects exhibit 
lower CASH allocation and higher BOND allocation than subjects with 
intermediate levels of testosterone. As such, gender and recent past 
performance effects render subjects with intermediate levels of testosterone 
more risk averse than subjects with high or low testosterone levels during 
rebalancing investment tasks. These results support those of Stanton et al. 
(2011), which show that low and high testosterone subjects exhibit decreased 
aversion to economic risk. Their results, like those in this study, are also 
significant in the presence of significant nonspecific gender differences. 
Therefore, the results here show that the study of the relation between 
testosterone and investment decision making should consider the influence of 
gender, recent past performance, and whether financial decisions are made for 
the first time.  
3.5.2. Testosterone and Portfolio Investment Performance 
   In order to better understand the role of testosterone on asset allocation 
decisions, including its role on rebalancing choices, it is necessary to analyze 
how the securities behave as a portfolio. In other words, I investigate whether the 
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characteristics of the entire portfolio of assets provide additional information 
about subjects’ financial preferences not otherwise evident by examining their 
preferences for individual assets. Table 3.5 displays the relation of Sal-T to 
several of these portfolio characteristics during DIV1, including the portfolio’s 
expected return and volatility, and the value at risk.30  
 Table 3.5 shows significant linear relations between testosterone levels 
and the portfolio’s expected return, volatility, VaR, shortfall and final wealth for 
the DIV1 task. Specifically, Sal-T has a strong negative relation to the expected 
return, volatility, and final wealth of the portfolio, and a strong positive relation 
with VaR and shortfall. These results are consistent with the results displayed in 
Panel A of Table 3.4, which shows that Sal-T has a negative relation with the 
proportion of funds invested in high-risk securities, and a positive relation with the 
proportion of funds invested in low-risk securities. As such, the results show that 
investors with higher levels of testosterone prefer low-risk securities and avoid 
high-risk securities. This results in portfolios with significant lower expected 
return, volatility and final wealth than the portfolios of subjects with lower levels of 
testosterone. Furthermore, the results show that the portfolios of subjects with 
lower levels of testosterone are subject to greater downside risk than the 
portfolios of subjects with higher levels of testosterone.  
 Table 3.5, also shows that Sal-T exhibits a significant positive relation to 
the portfolio Sharpe ratio, which measures the risk-adjusted performance. In 
                                                            
30 Additionally, only results pertaining to DIV1 are displayed, because there are no significant 
results for DIV2. I find that subjects allow their DIV1 performance to significantly influence their 
decisions during DIV2, overwriting the influence of testosterone. 
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other words, subjects with higher testosterone levels create portfolios with a 
greater return per level of risk undertaken, compared to subjects with lower 
testosterone levels. The fact that expected return and risk-adjusted return are 
negatively correlated has to do with the larger magnitude of the variance relative 
to that of the expected return. In terms of investment decisions, the results show 
that high testosterone subjects are mainly concerned with the mean and variance 
of the return distribution—therefore, their higher Sharpe ratios. Alternatively, low 
testosterone subjects consider higher moments of the return distribution (i.e., 
skewness), and therefore focus on avoiding extreme adverse events—therefore, 
lower VaR and shortfall.   
The results also show that testosterone does not always have a linear 
relation to the predicted performance of the portfolio. In particular, Sal-T has a 
strong negative relation to the portfolio abnormal return. This result is interesting, 
considering that it is the only measure of portfolio performance in Table 3.5 to 
exhibit a curvilinear relation with testosterone. Unlike other measures analyzed, 
abnormal return is an atypical measure, in that it is both a measure of return and 
a measure of risk. This characteristic could explain the unique relation between 
abnormal return and Sal-T. Alternatively, it could also mean that abnormal return 
helps to capture a unique aspect of testosterone’s role on financial decision 
making; namely, its combined influence on risk and reward preferences.       
Interestingly, for DIV2 no relation exists between Sal-T and any of the 
measures of expected portfolio performance. Instead, a strong linear relation 
between the performance in DIV1 (i.e., net liquidity value) and the 
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aforementioned portfolio characteristics is obtained.31 The strong influence of 
DIV1 performance on DIV2 allocation choices is further evidence that investors 
regard DIV2 as a rebalancing of their DIV1 portfolios, rather than as a new 
portfolio formation task. As such, the results show that portfolio rebalancing 
involves a different psycho-physiological mechanism of decision making than the 
initial portfolio formation—namely, one in which testosterone plays a much 
smaller role, and in which recent past performance is a key factor. 
 Overall, the results in Table 3.5 contrast with those of Coates and Herbert 
(2008), who show that higher morning levels of testosterone in a sample of floor 
traders is related to higher final wealth in the afternoon. A key important 
difference between their study and this one is the type of financial task. Floor 
traders engage in high-frequency trading, which requires constant attention to 
intraday price patterns and quick decision making. In this study portfolio 
formation is not as physically demanding as high-frequency trading, and 
decisions are made with less time constrains and for longer time horizons. In 
fact, Coates et al. (2009) propose that the positive correlation between 
testosterone and profitability during high-frequency trading “could even reverse 
sign among traders who adopt a more analytical and long-term approach to the 
markets.” The results in this study are consistent with this view.  
The results displayed in Table 3.5 also contradict Stanton et al. (2011), 
who show that Sal-T has a concave-up (U-shape) relation to risk aversion; 
meaning that individuals with intermediate levels of testosterone are more risk 
                                                            
31 These results are not shown because no relation between the performance measures during 
DIV2 and testosterone levels exists. The objective of this study is to address this relation.  
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averse than individuals with low and high testosterone (relative to their gender). 
However, the results in Table 3.5 only support the risk-aversion difference found 
between low- and intermediate-testosterone level individuals; specifically, that 
low-testosterone individuals take greater risks, and achieve greater profits, than 
individuals with intermediate levels of testosterone. In order to corroborate the 
findings for high-testosterone individuals, the quadratic term in Table 3.4 would 
need to be significant and positive. Adding to the inconsistency in findings 
between this study and Stanton et al. (2011), other studies show that the relation 
between testosterone and risk aversion is linear and positive for men (Apicella et 
al. 2008), and linear and negative for women (Sapienza et al. 2009).  
3.5.3. Testosterone and the Efficient Frontier 
 The last part of the analysis on investment decision making addresses the 
relation between testosterone levels and portfolio efficiency. As discussed in 
Appendix C, portfolio efficiency is measured as the horizontal distance between 
portfolios and the efficient frontier. Table 3.6 displays the results for DIV1 (Panel 
A) and DIV2 (Panel B). 
 The results displayed in Table 3.6 show that under different asset 
allocation tasks, testosterone creates a different relation with portfolio efficiency. 
During the initial portfolio-formation task (DIV1) a significant negative quadratic 
(concave down) relation exists between Sal-T and the horizontal distance of a 
portfolio to the efficient frontier. In other words, subjects with low and high 
testosterone levels create less efficient portfolios than subjects with intermediate 
levels of testosterone. Alternatively, during subsequent portfolio rebalancing, the 
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relation between testosterone levels and portfolio efficiency is negative and 
linear, showing that subjects with higher testosterone levels create less efficient 
portfolios during reallocation decisions than subjects with lower testosterone 
levels. To my knowledge, this is the first study to show the relation between 
testosterone levels and portfolio efficiency. .  
 Overall, the results from the portfolio formation tasks (DIV1 and DIV2) 
show that testosterone has a complex relation to asset allocation during 
investment decisions. The memory of recent past performance and gender 
differences can significantly interfere with the influence of testosterone on 
subsequent asset allocation decisions. However, asset allocation choices (Table 
3.4) and the resulting portfolio efficiency (Table 3.6) show the persistent influence 
of testosterone under portfolio rebalancing decisions.  
3.6. Testosterone and Options Trading Decisions and Outcome 
3.6.1. Options Trading Performance Overview 
 The relation between testosterone and trading decisions and outcomes is 
analyzed during an options trading task. Subjects could trade up to four different 
European option contracts written on the same non-dividend paying stock; 
namely two call options with strike prices of $25 (25C) and $26 (26C), and two 
put options with strike prices of $24 (24P) and $25 (25P). The stock was not 
tradable, but its price was observable. Table 3.7 summarizes the performance 
during the options trading task. All prices and profits and losses are in dollars.   
 At the end of the trading period, the stock had a value of $25.93. As such, 
all but the 25C contract expired out-of-the-money. Therefore, the trading 
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performance results in Table 3.7 show that the average subject incurred losses 
(negative P&L’s) in all but the 25C contract. However, the 25C gains were 
sufficiently large to result in a positive overall portfolio P&L. Interestingly, 25C 
was the most traded contract, having the largest number of buy orders, sell 
orders, market orders, and limit orders. These results show that subjects had 
optimistic expectations for future stock prices in general. Moreover, the evident 
preference for 25C over the 26C contract shows a preference for risk taking, 
since at-the-money options (i.e., 25C) possess higher deltas than out-of-the-
money options (i.e., 26C). Such preference for risk taking is evident in the large 
variability of the P&L levels. Figure 3.1, which shows the price path of the options 
contracts, confirms this conjecture.  
 Figure 3.1 shows that soon after trading starts, the prices of the options 
increase dramatically for all contracts except 24P. In some cases, the price rises 
to surpass the price of the underlying stock. Such cases constitute violations of 
the theoretical upper price limit of the options, because they introduce arbitrage 
opportunities between the stock and the options. However, in this task, the stock 
is not tradable, and arbitrage is not possible. Therefore, the dramatic price 
increases are most likely due to the actions of speculators or naïve traders.   
3.6.2. Testosterone and Options Contract Choice 
 In order to determine whether testosterone is related to trading choices 
and performance during the options trading task, I employ the three regression 
models introduced in section 3.4.1. Table 3.8 displays the significant relation 
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between Sal-T and investor trading preferences among the four types of option 
contracts.  
 Table 3.8 provides several takeaways. First, testosterone is preferentially 
related to puts. Table 3.7 shows that the majority of put orders submitted are buy 
orders. As such, the results show that testosterone level is related to having a 
pessimistic view about future stock prices. If holding the stock was allowed (as in 
the real world), the results also could mean that the testosterone level is related 
to hedging a long position on stocks using put options. Overall, the results in 
Table 3.8 are supported by medical studies showing that brain areas involved in 
anticipation of uncertain gains (e.g., showing optimism by buying call options) 
and losses (e.g., showing pessimism by buying put options) are different 
(Knutson and Cooper 2005).  
 Second, testosterone is related to option moneyness. High and low 
testosterone subjects have lower preference for at-the-money options (i.e., 25P 
and 25C) than subjects with intermediate levels of testosterone. At-the-money 
options are the least conservative of the four options contracts, because they 
undergo a greater change in price for a given change in stock price. Therefore, 
the results show that intermediate levels of testosterone are related to greater 
risk taking. Third, testosterone is negatively related to extreme risk taking. 
Specifically, the testosterone level has a negative relation to selling a naked call, 
which is the riskiest position attainable during the trading simulation.32 Therefore, 
the results show that testosterone levels do not have a linear relation to risk 
                                                            
32 Of the four possible combinations between buy/sell and put/call, selling a call without owning 
the stock (i.e. naked call) is the only one with unlimited potential losses.  
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taking during trading. In fact, extreme and irrational risk taking (e.g., selling 
naked call options), takes place under low levels of testosterone. Overall, the 
results in Table 3.8 show that testosterone is related to trading risk, which 
contradicts Coates and Herbert (2008).      
3.6.3. Testosterone and Order Type 
 The choice of submitting a limit or a market order is another important 
decision undertaken during trading. Table 3.9 shows that testosterone is 
significantly related to this choice. Specifically, testosterone level is negatively 
related to the submission of limit orders and positively related to the submission 
of market orders. The meaningful financial implications of the results in Table 3.9 
are discussed below.  
 First, a preference for limit or market orders can be due to trader attitude 
on immediacy. According to Glosten’s (1994) equilibrium model of the limit-order 
book, traders can be broadly defined as “patient” traders if they place limit orders 
and supply liquidity to the market or as “urgent” traders if they place market 
orders and consume liquidity. Under Glosten’s (1994) framework, informed 
traders are more likely to be urgent traders.33 Therefore, according to the results 
in Table 3.9, informed/urgent traders are high testosterone traders, whereas 
uninformed/patient traders are low testosterone traders. These results provide a 
biological explanation for the theoretical models of order flow in the market 
microstructure literature (e.g., Handa and Schwartz 1996; Foucault 1999). Such 
models predict that asset volatility changes lead to changes in the proportion of 
                                                            
33 This is because the value of private information decreases over time. Therefore, informed 
traders are better off submitting market orders, which are executed immediately.  
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limit orders submitted. Table 3.9 shows that an individual’s testosterone level is 
also a powerful predictor of limit order placement. In fact, changes in 
testosterone levels could be driving the changes in asset volatility, as suggested 
in Apicella et al. (2014).  
 Second, the preference for limit or market orders can be due to risk and 
reward preferences. That is, limit orders have non-execution risk, whereas 
market orders are executed with certainty. Additionally, in the real world, traders 
submitting limit orders face adverse selection risk due to the arrival of informed 
traders (Ahn et al. 2001). Alternatively, when a limit order is executed, trade 
occurs at a more favorable price than a market order. The results in Table 3.9 
show that traders with high testosterone levels are more likely to submit market 
orders, whereas traders with low testosterone levels are more likely to submit 
limit orders. Therefore, the results show that testosterone is significantly related 
to decisions regarding the balance between trading risk and reward. 
3.6.4. Testosterone and Trading Time Preferences 
 In addition to choosing which type of order to submit and what volume to 
trade, subjects must also decide when to trade—that is, time related choices. 
The results, displayed in Table 3.10, are as follows: First, subjects with high 
testosterone levels wait longer to initiate trading than subjects with low 
testosterone levels. Bosch-Domenech et al. (2014) reach a similar conclusion 
after showing that prenatal testosterone levels in a large sample (n=623) predict 
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scores on the Cognitive Reflection Test (CRT).34 Given the positive relation 
between testosterone levels and CRT scores, the results show that testosterone 
is related to deliberation and reflection of financial choices prior to engaging in 
trading. These results have obvious practical implications for real traders. For 
example, day traders could better understand why some of them commence 
trading precipitously, whereas others take more time.    
 Second, subjects with high testosterone levels submit their last order (i.e., 
stop trading) significantly sooner than subjects with low testosterone levels. This 
is congruent with high testosterone subjects having greater preference for market 
orders over limit orders (Table 3.9). Indeed, Garvey and Wu (2010) show that 
market orders benefit the most from higher trading speed. The literature also 
shows that greater speed of offset (i.e., how quickly trades are offset) is a 
fundamental aspect of trader discipline (Locke and Mann 2005).35 Therefore, the 
results show that subjects with higher testosterone levels possess greater trading 
discipline than subjects with lower testosterone levels. Note that for professional 
traders and aspiring average investors greater trading discipline is linked to 
future trading success (Locke and Mann 2005). Because traders can train to 
discipline themselves, such information will help them become more 
                                                            
34 The Cognitive Reflection Test was developed by Frederick (2005). It measures the tendency to 
engage in deliberation and reflection to arrive at correct answers, rather than provide an intuitive 
and incorrect response.  
 
35 Trading discipline is the tendency to cut losses short and let profits run. The opposite tendency 
is known as the disposition effect, in which traders hold on to losing positions for too long and sell 
winning positions too soon.  
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accomplished traders. In particular, monitoring their levels of testosterone could 
help them ensure that they are achieving and maintaining discipline.  
3.6.5. Testosterone and Options Trading Performance 
 Table 3.11 displays the relation between testosterone and trading 
performance. The results show that subjects with higher levels of testosterone 
achieve better risk adjusted performance (in terms of the coefficient of variation) 
than subjects with lower levels of testosterone. Note that subjects with high 
testosterone levels achieve superior risk adjusted performance on options 
contracts where the average subject realized large losses, namely 24P and 26C 
(Table 3.7). Furthermore, both of these contracts expired out-of-the-money. 
These facts show that a high level of testosterone provides a competitive 
advantage in predicting negative financial outcomes. Indeed, medical studies 
show that the amygdala, which is a main target of testosterone in the brain, is 
associated with the anticipation of negative outcomes (Schulkin et al. 1994). 
Additionally, the coefficient of variation is better at predicting risk sensitivity (i.e., 
the probability of choosing a riskier or less risky option) than normative risk 
measures, such as variance (Weber et al. 2004). Therefore, the results support 
Coates and Herbert’s (2008) hypothesis that testosterone influences trading 
profits via the role that it plays in setting risk preferences.   
3.7. Conclusions  
 In this study, I analyzed the relation of testosterone to financial choices 
and performance during a portfolio formation task and an options trading task. I 
purposely selected these tasks to distinguish between carefully thought-out, long-
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term financial choices (i.e., investment choices) and high-speed, stressful 
financial choices (i.e., trading choices). Coates et al. (2009) postulate that the 
role of testosterone on financial decisions and outcome depends on the time 
pressures associated with financial tasks. However, the literature has not 
answered how testosterone’s influence on financial decision making is different 
under investment and trading tasks. To my knowledge, this is the first study to 
address this distinction.  
 Overall, the results of this study show that under investment tasks, 
testosterone plays a crucial role during initial asset allocation decisions. 
Testosterone plays a lesser role during subsequent rebalancing choices, which 
are primarily driven by the memory of recent past performance. These results 
show that first-time investors can benefit from understanding the effect of 
testosterone on their financial decisions. Similarly, the results can be helpful to 
professional financial planners to better understand the financial choices of first-
time investors.  
 With the advent of online discount brokerage services, many naïve 
investors are making quick trading decisions similar to the decisions made during 
the options trading task. The results of this study show that testosterone is 
significantly related to many aspects of trading, including the choice of security, 
order type, and time related preferences. Additionally, risk adjusted performance 
is positively correlated with testosterone levels. This is good news for those who 
worry about the effects of “testosterone poisoning” on financial markets. Contrary 
to the popular notion that testosterone leads to excessive risk taking and 
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suboptimal financial decisions, I find that subjects with relatively high 
testosterone levels display qualities of profitable traders, such as discipline and 
choice deliberation under pressure. Therefore, this study strongly advocates for 
the continuation of research on the role of testosterone on financial choices and 
outcomes. It is my view that financial markets could be made safer and more 
efficient if individual market players learn to harness the influence of testosterone 
on their financial decision making.    
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Table 3.1 
Asset Allocation Choices 
The table displays the average proportion of funds allocated into each of the five 
risky securities (HOME, GROW, BOND, MINE, MMKT), or left uninvested 
(CASH) during DIV1 and DIV2. The historical return and volatility of each security 
is displayed below its name. Volatility is displayed in parentheses 
 
 
HOME 
* 
8.5% 
(18%) 
GROW 
* 
13% 
(30%) 
BOND 
* 
4.5% 
(8%) 
MINE 
* 
6.0% 
(16%) 
MMKT 
 
2.0% 
(1%) 
CASH 
*** 
0% 
(0%) 
DIV1 22.9% 
(17.5%) 
23.7% 
(14.1%) 
12.7% 
(9.4%) 
13.7% 
(11.3%) 
7.0% 
(8.6%) 
20.0% 
(29.4%) 
DIV2 26.3% 
(16.1%) 
27.4% 
(13.8%) 
15.2% 
(11.8%) 
17.3% 
(11.2%) 
6.9% 
(8.9%) 
6.9% 
(19.4%) 
Notes: Mean differences between DIV1 and DIV2 are tested via a paired two-
sample t-test. Significance is displayed at the 10% (*), 5% (**) and 1% (***) 
levels. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
70 
Table 3.2 
Portfolio Return and Volatility 
The table displays the expected and realized return and volatility of portfolios 
during DIV1 and DIV2. Standard deviations are shown in parentheses.  
 Expected Realized 
 Return 
*** 
Volatility 
** 
Return 
*** 
Volatility 
*** 
DIV1 7.90% 
(2.49%) 
11.56% 
(4.71%) 
9.91% 
(3.44%) 
11.79% 
(4.81%) 
DIV2 8.81% 
(1.84%) 
13.42% 
(4.33%) 
1.29% 
(0.60%) 
13.34% 
(4.28%) 
Notes: Mean differences between DIV1 and DIV2 are tested via paired two-
sample t-test. Significance is displayed at the 10% (*), 5% (**) and 1% (***) 
levels. 
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Table 3.3 
Portfolio Performance 
The table shows various measures of expected and realized portfolio risk and 
return. The percentage shortfall represents the probability of falling short of 
reaching the investment objective of achieving a final portfolio value of $1.5 
million over 20 years. The final wealth is the portfolio value at the end of the 
investment period. The total portfolio return is the holding period return over the 
20 years, computed from an initial wealth of $500,000. The abnormal return is 
the yearly return in excess of the expected return predicted by the historical 
annual return of the securities. The Sharpe ratio is the difference between the 
annual return and the risk-free rate (which is zero for DIV1 and DIV2), divided by 
the return volatility. The value-at-risk (VaR) is the maximum loss expected over 
one year, with a 95% confidence interval. Standard deviations are shown in 
parentheses.  
 DIV1 DIV2
Shortfall *** 51.53% 
(18.09%)
45.45%
(12.60%)
Final Wealth (Realized) *** $3,799,634 
($1,653,338)
$650,399
($77,946)
Final Wealth (Expected) *** $2,478,087 
($835,455)
$2,831,813
($788,247)
Total Return (Realized) *** 659.93% 
(330.67%)
30.08%
(15.59%)
Total Return (Expected) *** 395.62% 
(167.09%)
466.36%
(157.65%)
Abnormal Return (Realized) *** 3.35% 
(1.53%)
-6.37%
(2.18%)
Abnormal Return (Expected) * 1.34% 
(0.68%)
1.55%
(0.55%)
Sharpe (Realized) *** 0.88 
(0.18)
0.11
(0.07)
Sharpe (Expected) * 0.74 
(0.15)
0.70
(0.18)
VaR *** -12.46% 
(5.33%)
-14.43%
(5.17%)
Notes: Mean differences between DIV1 and DIV2 are tested via paired two-
sample t-test. Significance is displayed at the 10% (*), 5% (**) and 1% (***) 
levels. 
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Table 3.4 
Testosterone Relation to Asset Allocation 
The table displays the coefficients for three regression models, where the 
proportion of funds allocated to each security or left uninvested (CASH) is the 
dependent variable. The proportion of funds allocated to Low Risk (CASH and 
MMKT), Medium Risk (BOND and MINE), and High Risk (GROW and HOME) is 
also analyzed. An additional fourth model is performed on DIV2 variables to 
control for the level of performance during DIV1. All tables only display the 
regression models with significant coefficients. 
 
Panel A: DIV1 
 Model Linear Sal-T Quadratic Sal-T Gender Reg. R2
GROW 1 **-47.19  0.12
 2 *-39.69 -14.89  0.13
BOND 1 *-27.67  0.09
 2 *-28.66 1.96  0.09
 3 *-29.26 2.18 -35.49 0.12
LOW RISK 1 *77.43  0.08
 2 *82.83 -10.72  0.08
 3 *81.06 -10.07 -103.87 0.11
HIGH RISK 1 **-66.86  0.10
 2 *-66.27 -1.16  0.10
 3 *-64.12 -1.95 *126.78 0.18
 
Panel B: DIV2 
 Model Linear Sal-T Quad. Sal-T Gender DIV1 NLV Reg. R2
BOND 3 *-31.26 *24.89 ***-108.76  0.28
MINE 1 **41.76  0.14
 2 **47.57 -12.04  0.15
 3 **47.63 -11.88 -24.35  0.17
 4 ***57.53 -4.80 -38.73 **39.39 0.28
CASH 4 -39.06 *-38.12 *105.36 ***-128.93 0.41
Notes: The explanatory variables are given by the model as follows: 
Model 1 has salivary testosterone (Sal-T) as the single explanatory variable. 
Model 2 introduces a quadratic term. 
Model 3 introduces a dummy variable for gender (Female=0, Male=1) 
Model 4 (DIV2 only) introduces the standardized Net Liquidation Value (NLV) of 
DIV1 to control for DIV1 performance.  
Regression coefficients are multiplied by 1,000 to show them more clearly. 
Sample regression R-squared is displayed in the last column. 
Significance is displayed at the 10% (*), 5% (**) and 1% (***) levels. 
 
 
 
73 
Table 3.5 
Relation of Testosterone to Expected Portfolio Performance  
The table displays the coefficients for three regression models, where the 
dependent variable is a measure of expected portfolio performance. These 
measures, which are computed via Monte Carlo simulations, include the portfolio 
annual return, annual volatility, value at risk (VaR), final wealth, Sharpe ratio, 
percent shortfall and abnormal return.  
 Model Linear Sal-T Quadratic Sal-T Gender  Reg. R2
Return 1 **-8.34  0.11
 2 *-7.09 -2.48  0.13
Volatility 1 **-15.75  0.11
 2 *-14.86 -1.78  0.12
 3 *-14.51 -1.90 20.16 0.16
VaR 1 **18.16  0.12
 2 *16.78 2.73  0.12
 3 *16.39 2.88 -22.99 0.16
Final Wealth 1 **-270,934  0.11
 2 *-249,023 -43,506  0.11
 3 *-244,798 -45,050 248,908 0.13
Sharpe ratio 1 *54.50  0.09
Shortfall 1 *50.57  0.08
Abn. Return 2 0.55 **-2.27  0.17
 3 0.49 **-2.25 *-3.74 0.23
Notes: The explanatory variables are given by the model as such: 
Model 1 has salivary testosterone (Sal-T) as the single explanatory variable. 
Model 2 introduces a quadratic term. 
Model 3 introduces a dummy variable for gender (Female=0, Male=1) 
Model 4 (DIV2 only) introduces the standardized Net Liquidation Value (NLV) of 
DIV1 to control for DIV1 performance.  
Regression coefficients (except those of Final Wealth) are multiplied by 1,000 to 
show them more clearly. 
Sample regression R-squared is displayed in the last column. 
Significance is displayed at the 10% (*), 5% (**) and 1% (***) levels. 
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Table 3.6 
Testosterone Relation to Portfolio Efficiency  
The table displays the coefficients for three regression models, where the 
dependent variable is the horizontal distance to the efficient frontier. This 
horizontal distance, labeled “SDiff” is the difference between the portfolio 
standard deviation, and the standard deviation of the efficient portfolio of same 
expected return.  
 Model Linear Sal-T Quadratic Sal-T Gender Reg. R2
DIV1 SDiff 2 -0.75 *-2.73  0.11
 3 -0.74 *-2.74 0.62 0.11
DIV2 SDiff 1 *-2.84  0.09
 3 *-2.53 -0.71 *5.67 0.18
Notes: The explanatory variables are given by the model as follows: 
Model 1 has salivary testosterone (Sal-T) as the single explanatory variable. 
Model 2 introduces a quadratic term. 
Model 3 introduces a dummy variable for gender (Female=0, Male=1) 
Model 4 (DIV2 only) introduces the standardized Net Liquidation Value (NLV) of 
DIV1 to control for DIV1 performance.  
Regression coefficients are multiplied by 1,000 to show them more clearly. 
Sample regression R-squared is displayed in the last column. 
Significance is displayed at the 10% (*), 5% (**) and 1% (***) levels. 
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Table 3.7 
Options Trading Summary Performance 
The table displays several measures of performance during the options trading 
task for each of the four tradable option contracts and for the total portfolio. The 
name of the contract is the strike price (i.e., 24, 25, or 26) followed by the letter 
"P," for put, or the letter "C," for call. From top to bottom of column 1, the 
measures analyzed are: the realized profit or loss after trading stops (P&L), the 
standard deviation of P&L (SD P&L), the average number of orders submitted 
(Avg. No. Orders), the average order size submitted (Avg. Order Size), the total 
number of market orders submitted (No. Market), the total number of limit orders 
submitted (No. Limit), the total number of buy orders (No. Buys), and the total 
number of sell orders (No. Sells). Where appropriate, standard deviations are 
displayed in parentheses.  
 24P 25P 25C 26C Total
P&L -660 
(6814)
-6,892 
(243,651)
14,673
(803,518)
-2,316 
(691,388) 
4,805
(1,345,916)
SD P&L 1,697 
(2,956)
63,284 
(98,890)
151,573
(201,594)
126,181 
(277,131) 
297,613
(497,800)
Avg. No. Orders 4 
(7)
4 
(4)
8
(12)
5 
(8) 
21
(23)
Avg. Order Size 47 
(49)
58 
(47)
65
(43)
60 
(46) 
77
(34)
No. Market 130 133 180 138 581
No. Limit 28 46 149 97 130
No. Buys 124 136 226 139 625
No. Sells 34 43 103 96 276
No. Orders 158 179 329 235 901
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Table 3.8 
Testosterone, Number of Orders, and the Decision to Buy or Sell  
The table displays the coefficients for three regression models, where the 
dependent variable is the buy, sell and overall (i.e. buy plus sell) number of 
orders submitted per contract type as a percentage of the total number of orders 
submitted. From top to bottom of column 1, the dependent variables are: the 
number of 25P orders, number of put orders (both 25P and 24P), number of 
orders for at-the-money options (i.e. those with strike price K=25), number of 24P 
buy orders, and number of 26C sell orders. 
 Model Linear Sal-T Quad. Sal-T Gender Reg. R2
25P Orders 2 *53.73 -18.12  0.07
 3 *53.61 -17.87 -40.25 0.08
Put Orders 1 *52.98  0.07
Call Orders 1 *-52.98  0.07
25K Orders 2 32.65 *-55.46  0.07
 3 32.78 *-55.71 40.77 0.08
24P Buys 3 16.57 *22.83 **-86.05 0.25
26C Sells 1 *-30.02  0.07
 2 **-37.16 14.74  0.09
 3 **-36.99 14.39 56.96 0.15
Notes: The explanatory variables are given by the model as follows: 
Model 1 has salivary testosterone (Sal-T) as the single explanatory variable. 
Model 2 introduces a quadratic term. 
Model 3 introduces a dummy variable for gender (Female=0, Male=1) 
Sample regression R2 is displayed in the last column. 
Regression coefficients are multiplied by 1,000. 
Significance is displayed at the 10% (*), 5% (**), and 1% (***) levels. 
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Table 3.9 
Testosterone and the Choice of Limit or Market Orders 
The table displays the coefficients for three regression models, where the 
dependent variable is the number of limit (Panel A) and market (Panel B) orders 
submitted for each option contract as a proportion of the total number of orders 
submitted by the subject.  Additionally, “Limit Orders” and “Market Orders” (the 
last variable of each panel) is the total proportion of limit and market orders 
submitted, respectively.  
 
Panel A: Limit Orders 
 Model Linear Sal-T Quadratic Sal-T Gender Reg R2
24P Limit  1 **-30.27 0.12
 2 ***-38.78 17.58 0.18
 3 ***-38.76 17.53 8.22 0.18
25C Limit 1 **-75.15 0.12
 2 *-66.14 -18.60 0.13
 3 *-65.95 -18.98 62.09 0.15
26C Limit 1 ***-78.85 0.20
 2 ***-111.30 ***66.98 0.40
 3 ***-111.02 ***66.41 **94.21 0.46
Limit Orders 1 ***-208.66 0.25
 2 ***-237.02 58.54 0.27
 3 ***-236.54 57.56 161.84 0.31
 
Panel B: Market Orders 
 Model Linear Sal-T Quadratic Sal-T Gender Reg.R2
25P Market 1 **69.34  0.14
 2 **74.52 -10.70  0.14
 3 **74.41 -10.47 -37.58 0.15
26C Market 1 **65.03  0.11
 2 **83.84 -38.84  0.16
 3 **83.80 -38.74 -15.83 0.16
Market orders 1 ***208.66  0.25
 2 ***237.02 -58.54  0.27
 3 ***236.54 -57.56 -161.84 0.31
Notes: The explanatory variables are given by the model as follows: 
Model 1 has salivary testosterone (Sal-T) as the single explanatory variable. 
Model 2 introduces a quadratic term. 
Model 3 introduces a dummy variable for gender (Female=0, Male=1) 
Sample regression R2 is displayed in the last column. 
Regression coefficients are multiplied by 1,000. 
Significance is displayed at the 10% (*), 5% (**), and 1% (***) levels. 
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Table 3.10 
Testosterone and Trading Time Preferences 
The table displays the coefficients for three regression models, where the 
dependent variables are, from top to bottom of column 1: the time (in seconds) at 
which the first order was submitted, the time at which the last order was 
submitted, and the time difference between the last and first order submission 
(Trading Time).  
 Model Linear Sal-T Quadratic Sal-T Gender  Reg. R2
First Order 1 **15.34  0.11
 2 **16.56 -2.53  0.12
 3 **16.61 -2.62 14.87 0.14
Last Order 2 *-12.16 6.32  0.10
 3 *-12.16 6.31 1.66 0.10
Trading Time 1 ***-24.44  0.16
 2 ***-28.73 8.85  0.19
 3 ***-28.77 8.93 -13.21 0.20
Notes: The explanatory variables are given by the model as follows: 
Model 1 has salivary testosterone (Sal-T) as the single explanatory variable. 
Model 2 introduces a quadratic term. 
Model 3 introduces a dummy variable for gender (Female=0, Male=1) 
Sample regression R2 is displayed in the last column. 
Significance is displayed at the 10% (*), 5% (**), and 1% (***) levels. 
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Table 3.11 
Testosterone and Options Trading Performance  
The table displays the coefficients for three regression models, where the 
dependent variables are measures of trading performance on individual option 
contracts. These are the final profit and loss value (P&L), the coefficient of 
variation (CV), standard deviation of net liquidity value (SD NLV), and the range 
of net liquidity value.  
 Model Linear Sal-T Quadratic Sal-T Gender Reg.R2
P&L 24P 1 **-2,164  0.10
 2 *-1,937 -467  0.10
 3 *-1,931 -480 1,969 0.12
CV 24P 1 **0.12  0.14
 2 **0.13 -0.01  0.14
 3 **0.13 -0.01 *-0.18 0.20
CV 26C 1 *0.10  0.08
 2 **0.13 -0.06  0.12
 3 **0.13 -0.06 -0.09 0.14
SD NLV 25C 2 9,688 **-54,044  0.10
 3 9,798 **-54,270 37028 0.11
Range NLV 25C 2 9,866 **-177,483  0.10
 3 10,150 *-178,069 95,932 0.11
Notes: The explanatory variables are given by the model as follows: 
Model 1 has salivary testosterone (Sal-T) as the single explanatory variable. 
Model 2 introduces a quadratic term. 
Model 3 introduces a dummy variable for gender (Female=0, Male=1) 
Sample regression R-squared is displayed in the last column. 
Significance is displayed at the 10% (*), 5% (**), and 1% (***) levels. 
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Figure 3.1 
Option Price Path 
The figure shows the price path followed by each option contract during the five 
minutes of trading. Time is expressed in seconds. The price displayed is the 
closing price for each second. 
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CHAPTER 4: STRESS AND FINANCIAL CHOICES 
4.1. Introduction 
 In this essay, I examine the relation between cortisol levels (the biological 
barometer of stress levels) and financial decision making.36 It is widely held that 
stress is rampant among finance professionals, including traders and fund 
managers, and a clear connection exists between stress and cognitive 
processes. Yet the specific role of stress on financial choices and outcomes has 
only recently been addressed, and then only by a limited number of studies (the 
literature is summarized below). The present study represents one of the first 
comprehensive efforts to understand the role of stress on financial decision 
making. Specifically, this study is important to the literature because it 1) 
analyzes the role of stress under fundamentally different financial tasks (i.e., 
investing and trading), 2) considers a wide variety of investment choices, 3) 
examines both male and female subjects, and 4) takes place in a controlled 
environment, avoiding the confounds associated with field studies.   
 The present study differs from the financial literature in several important 
ways. First, it is one of the few studies in finance to measure the stress level of a 
financial task using its closest biological correlate (i.e., the individual’s cortisol 
level). This is extremely important because stress is notoriously difficult to 
quantify objectively by other means (e.g., self-reports, psychological tests, etc.). 
Therefore, the measure of stress level used in this study is unbiased from 
                                                            
36 In humans, cortisol is secreted by the adrenal glands into the blood in response to stressful 
stimuli. Therefore, the circulating level of cortisol (versus cortisol that is stored in the adrenal 
glands) is the primary biological marker of stress.  
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personal observations. Second, it is the only study (known to the investigator) to 
examine the role of stress on both investment and trading decisions made by the 
same group of individuals. As such, it avoids many of the problems associated 
with fairly comparing the results of subjects across different tasks. Finally, this 
study employs realistic financial tasks with real world parallels. The majority of 
other studies make use of economic games, like the IGT and the Ultimatum 
Game, that have few real world analogs. Therefore, the results of the present 
study are more relatable than those of other studies.  
 Overall, the results show that the relation of stress to financial decisions 
and outcomes is distinct for investing and trading tasks. During investing decision 
making, the higher the stress level, the more subjects tend to avoid high-risk 
securities, and the more they tend to prefer low-risk securities. Ultimately, 
investment performance is optimal under moderate levels of stress. Alternatively, 
during trading decision making, the influence of stress on risk-taking behavior is 
modulated by the stress appraisal process—in particular, whether an optimistic 
or pessimistic view about future stock prices is held. Ultimately, trading 
performance is optimal under either high or low levels of stress. The resultant 
implications for financial decision makers, as well as the relevance for the finance 
literature, are discussed.    
 Financial decisions are stressful, and stressful stimuli cause the body to 
secrete cortisol into the bloodstream. Upon reaching the brain, cortisol plays a 
key role in the regulation of the cognitive processes necessary to deal with the 
financial task involved. The strength of the stress response depends primarily 
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upon the amount of cortisol released and the brain areas involved. The more 
potent the stimuli, the greater the amount of cortisol released, and consequently 
the greater its influence on the brain. Therefore, cortisol, and therefore stress, 
has a direct influence on financial decision making.  
 Different types of financial tasks require different kinds of financial 
decisions. Such decisions activate different areas of the brain and employ 
different cognitive processes. Therefore, we can hypothesize that the role of 
stress on financial decision making may be related to the type of financial task 
being performed. For example, short-term investment decisions (i.e., trading), 
such as decisions made by day traders, require high alertness, responsiveness, 
and quick problem solving. Alternatively, long-term investment decisions (i.e., 
investing), such as retirement planning decisions, can involve unhurried 
deliberation, introspection, and scenario analysis. This study examines the role of 
stress under both short-term trading and long-term investing tasks in order to 
capture any differences resulting from the different cognitive processes involved 
during each task.  
 Because of the limited body of work examining the role of stress on 
financial decision making, it is not clear how stress and financial performance are 
related. A widely accepted hypothesis in the health sciences (Conrad et al. 1999) 
shows an inverted U-shape relation between stress levels and cognitive function 
(sometimes known as the Yerkes–Dodson curve, in honor of the psychologists 
who first described it in 1908). According to this model, there is an optimal level 
of stress (neither too low nor too high) that maximizes performance on cognitive 
84 
and behavioral tasks. Maximizing performance on financial tasks is of outmost 
consequence for finance professionals. However, it is not known whether 
performance on financial tasks also exhibits an inverted U-shaped relation with 
stress levels. Therefore, this essay examines the relation of stress to trading and 
investing performance.  
 In addition to examining financial performance, or outcomes, this study 
also examines the relation of stress to decision making during investing and 
trading tasks, including the choice of asset allocation preferences, volumes 
traded, and timing of trades. To the best of my knowledge, this is the first study to 
examine these aspects of financial decision making. Therefore, this essay 
provides important information that could help finance professionals identify and 
deploy the profit-enhancing qualities of “good” stress, as well as cautions about 
excessive stress.  
4.2. Literature Review 
  Occupational stress is particularly high among finance professionals 
(Jones et al. 2003), and it can result in behavioral problems, such as mental 
disorders (Dias 1990) and elevated alcohol consumption (Kahn and Cooper 
1990). Oberlechner and Nimgade (2005) surveyed a large sample of foreign 
exchange traders (n=326), showing that “pressure to achieve the profit goal” is 
reportedly the greatest source of stress, followed by “long working hours” and 
“time pressure.” These results are not unexpected, but they do not provide 
finance professionals with useful solutions. For one, the aforementioned sources 
of stress are part of the job requirements for traders; therefore they cannot be 
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mitigated. Additionally, self-reported information fails to address stress sources 
that are outside of an individual’s awareness. For example, Lo and Repin (2002) 
show that traders exhibit changes in heart rate, blood pressure, and skin 
conductance concurrently with transient market events. Such instinctual 
physiological responses to financial stimuli are consistent with the experience of 
stress. Therefore, biological markers of stress, such as cortisol levels, provide a 
superior method to study the relation between stress and financial decision 
making.  
 Salivary cortisol (Sal-CO) is the preferred method used by researchers for 
measuring circulating levels of cortisol in the body, due to the noninvasiveness of 
this approach. Coates and Herbert (2008) examine the relation of Sal-CO to 
financial performance in a small sample of male floor traders (n=17). The authors 
find no evidence that cortisol levels are related to trading gains or losses (P&L). 
Instead, they show that cortisol levels possess a significant positive linear 
relation to standard measures of risk, such as the variance of profits and the 
volatility of the market. In addition to the standard measures of risk, the present 
study considers various other risk measures and risky choices. I choose 
alternative measures because standard measures of risk are suboptimal 
predictors of risk preferences (Weber et al. 2004). Additionally, studies show the 
opposite relation between stress and risk taking as described by Coates and 
Herbert. For example, van Honk et al. (2003) show that cortisol levels correlate 
positively with risk aversion (instead of risk taking) in subjects playing the Iowa 
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Gambling Task (IGT).Therefore, one of the main objectives of the present study 
is to resolve such contradictory findings.   
 Due to the embryonic state of the literature on this subject, it is premature 
to draw any conclusions from Coates and Herbert (2008). However, their study is 
the closest available for comparison to the study here, although my study differs 
in the following key respects: I analyze the relation of cortisol to financial 
decisions made during trading and investing tasks. Moreover, I use a sample of 
male and female naïve financial decision makers, whereas Coates and Herbert 
employ a sample of male professional traders. Therefore, the results of the 
present study are easier to apply to a broader range of investors than the results 
provided by Coates and Herbert. Finally, this study is free of trader selection 
bias, as I do not exclude subjects on the basis of their (lack of) trading skills. 
Such bias occurs in the Coates and Herbert study because even the least 
experienced professional trader is carefully selected from a large pool of 
applicants on his/her merit as a “good” trader.37 Therefore, individual professional 
traders should be able to cope the best with trading-related stress. Also note that 
the lack of a relation between cortisol levels and trader P&L levels in the Coates 
and Herbert sample could be the result of the superior stress-coping skills of 
individuals in their sample.  
4.3. Methodology 
 The participants and procedure used is described in Section 3.2, 
“Testosterone and Financial Choices.” However, the current study concerns the 
                                                            
37 It is common practice to put applicants through trading simulations and trial periods before 
hiring them as traders.  
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role of stress on financial decision making, and therefore is concerned with 
salivary levels of cortisol (Sal-CO). As described in Section 3.2, saliva collection 
occurs after provoking stress in subjects and prior to the financial tasks. 
Therefore, the resulting stress level observed is a “before the fact” measure that 
cannot be attributed to the financial decision making process. That is, the results 
obtained in this study show the influence of stress on financial choices and 
outcome, and not the other way around.  
 The mean Sal-CO concentration in the sample is 5.48 nmol/L (SD=3.07) in 
men and 8.55 nmol/L (SD=8.47) in women. There is no benchmark to compare 
these levels, since the Sal-CO measurement (as with many other saliva 
measurements) is strongly related to the particular technique employed. Even 
studies that measure Sal-CO at the same time of day present significantly 
different Sal-CO concentrations. For example, Laudat et al. (1988) measure Sal-
CO at the same time of day as the present study. However, their sample exhibits 
a mean Sal-CO level of 15.5 nmol/L (SD=0.8), which is much higher than the 
mean Sal-CO of subjects in the present study. In fact, the Laudat et al. study 
shows that subjects with adrenal insufficiency (abnormally low levels of cortisol) 
have a mean Sal-CO level of 7.5 nmol/L (SD=0.4), which is more congruent with 
the results of this study.38 Due to these inconsistencies in the literature, raw 
levels of cortisol are standardized (converted to z-scores) in this study for all 
participants. The z-scores are used in all the analyses, making it easier for other 
                                                            
38 Therefore, if I compared the Sal-CO from this study with theirs would show the subjects in this 
study suffer from abnormally low levels of cortisol. 
88 
studies to compare their results to this research (as long as they too standardize 
raw cortisol levels).  
4.4. Results 
4.4.1. Stress and Investment Asset Allocation Decisions 
 The asset allocation decisions of subjects provide “before the fact” 
evidence of the role of stress on financial decision making during investment 
tasks. Table 4.1 displays the significant relations of stress to asset allocation 
decisions in the first portfolio-formation task (DIV1) in Panel A, and the second 
portfolio-formation task (i.e., the rebalancing task, DIV2) in Panel B.39 Overall, the 
results show that current levels of stress (i.e., Sal-CO) affects investment 
allocation preferences (i.e., what people invest in). Furthermore, whether 
allocation choices are made for the first time or subsequent times is important. In 
other words, the influence of stress on first-time investment choices is different 
than on subsequent choices. This is because subjects allow the memory of 
recent past performance to influence subsequent investment choices. Therefore, 
the influence of stress on reallocation choices is changed by the influence of the 
recent past performance.   
 Specifically, Panel A of Table 4.1 shows that during initial portfolio 
formation, a higher stress level (i.e., Sal-CO) is related to a higher allocation to 
low-risk securities, and a lower allocation to high-risk securities. A higher 
proportion of funds not invested in risky securities (i.e., CASH) is also related 
                                                            
39 Only regression models with significant testosterone coefficients are displayed. Although 
adding explanatory variables changed the significance of individual variables, the sample R-
squared remains the same.  
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positively to Sal-CO. These results are consistent with van Honk et al. (2003), 
who find that Sal-CO is correlated with risk aversion in the IGT. Therefore, the 
results show that stress plays an important role during initial investment 
decisions involving how much risk to undertake (or how much risk can be 
tolerated). Specifically, the higher the stress level, the more subjects tend to 
avoid high-risk securities, and the more they tend to prefer low-risk securities. 
Medical studies have addressed the mechanisms by which high stress can lead 
to risk aversion. In particular, sustained exposure to high cortisol levels can lead 
to anatomical changes in a primal part of the brain that deals with emotional 
responses (i.e., the amygdala), causing individuals to respond to stress with fear, 
anxiety (Davis 1992), and chronic anticipation of negative events (Schulkin et al. 
1994). Therefore, the preferential allocation of funds to low-risk securities in high-
risk subjects could be the result of amygdala overstimulation, which mutes the 
ability to tolerate uncertainty or willingness to accept uncertainty.  
 Table 4.1, Panel B shows that cortisol is involved with a shift in attitude 
towards risk during repeated exposure to the asset allocation task. That is, during 
DIV2 subjects with different cortisol levels revise their allocation choices in the 
low risk MMKT security. Specifically, subjects with low and high cortisol levels 
allocate lower amounts of funds to MMTK than subjects with intermediate stress 
levels. These results are consistent with performance optimization under 
moderate levels of stress, as described by the inverted U-shaped Yerkes–
Dodson curve. In fact, the results on investment performance (discussed later) 
show that subjects with intermediate stress levels achieve higher abnormal return 
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than low and high-stress subjects. Therefore, the results show that subjects with 
moderate levels of stress learn from their recent past performance (i.e., the 
performance on DIV1) to make better allocation decisions during subsequent 
investment tasks (i.e., generating neither too little nor too much risk).  
 The reason why some subjects learn to make better allocation decisions 
after DIV1, whereas others do not make more optimal decisions, could be related 
to the ability to adapt to stressful tasks after repeated exposure. Medical studies 
show that repeated exposure to stressful stimulation results in attenuation of the 
stress response in some individuals, but not in others. For example, Kirschbaum 
et al. (1995) subject a sample of healthy male participants to a brief public 
speaking task once per day for five days. The study shows that while Sal-CO is 
high during the first day, it declines in some subjects during the subsequent days, 
but remains elevated in other subjects throughout the entire trial. The study also 
shows that subjects who are unable to habituate their stress response have 
characteristically low levels of self-esteem. Therefore, subjects who exhibit stress 
habituation after DIV1 could be better prepared to make rational asset allocation 
decisions during DIV2. Additionally, their study shows that subjects unable to 
habituate their response to stress have identifying personality traits.  
4.4.2. Stress and Expected Investment Performance 
    Expected portfolio performance is a direct consequence of asset 
allocation decisions. Therefore, the influence of stress on asset allocation 
decisions is reflected in the expected portfolio performance.  Table 4.2 displays 
the relation of Sal-CO to measures of expected portfolio performance during 
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DIV1.40 Some of the results are obvious given the relation between stress and 
asset allocation choices discussed in the previous section. For example, subjects 
with higher levels of stress invest in low-yield, low-risk securities, so naturally 
their portfolios are expected to have lower return and volatility than the portfolios 
of subjects with lower levels of stress. As a consequence, the chance of 
achieving the minimum required holding period return is also lower for high-
stress subjects. Such facts confirm what was already suspected (from the 
previous section, and the results of van Honk et al. 2003): high stress during 
initial portfolio creation results in risk averting choices, which results in portfolios 
with low return, low volatility and high shortfall. These results are particularly 
useful for first-time investors (or finance professionals who deal with first-time 
investors), because it shows that under duress they could create portfolios that 
do not fulfill their future expected consumption needs.  
 Other results in Table 4.2 are not forgone conclusions from the previous 
section (i.e., they are less obvious given the asset allocation results). For 
example, the greater the Sal-CO, the higher the Sharpe ratio and VaR values.41 
That is, subjects with greater levels of stress create portfolios with higher 
expected return-to-volatility ratios and higher expected loss under “extreme” 
                                                            
40 As mentioned in the previous section, subjects allow their DIV1 performance to significantly 
influence their decisions during DIV2. As a result, the influence of stress on rebalancing 
performance is masked by the powerful influence of the memory of recent past performance.   
 
41 The VaR is the maximum loss expected with 95% confidence over one investment period (i.e., 
one simulated year in this case). The likelihood of an extreme adverse event occurring with 95% 
confidence is 1.645 standard deviations below the mean in a Normal distribution. Therefore, the 
VaR is equal to -1.645 multiplied by the standard deviation plus the mean.   
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adverse events.42 At first, it may seem contradictory for subjects with high levels 
of stress to have high Sharpe ratio and high VaR, yet low return and low volatility. 
However, as Table 4.2 shows, the magnitude of the volatility coefficient is larger 
than the magnitude of the return coefficient. This means that although volatility 
and return are both decreasing in relation to Sal-CO (i.e. both are negatively 
correlated), volatility decreases at a faster rate than return does. This results in 
the aforementioned high Sharpe ratio and high VaR values.  
 Overall, how is stress related to investment risk and return? The answer to 
this question relates to the measures of risk and return. Expected return is a 
measure of gross return, whereas the Sharpe ratio is a measure of risk-adjusted 
return. Therefore, regarding the relation between stress and return, the results 
show that high-stress subjects are risk-adjusted performance maximizers, 
whereas low-stress subjects are gross performance maximizers. Regarding the 
relation between stress and portfolio risk, note that volatility is a measure of 
dispersion and uncertainty, whereas VaR (as with Shortfall) is a measure of 
downside risk and adverse outcomes. Therefore, the results show that high-
stress subjects are uncertainty minimizers, whereas low-stress subjects are 
downside risk minimizers.  
 In fact, a large body of theoretical work describes the existence of “safety-
first” investors who minimize the chance of extreme adverse outcomes (starting 
with Roy 1952). According to this literature, the allocation choices of safety-first 
                                                            
42 Technically the Sharpe ratio is the difference between the expected return and the risk-free rate 
divided by the standard deviation of returns. However, in this study the risk-free rate is zero in all 
tasks. Therefore, the Sharpe ratio is simply the expected return divided by volatility. 
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investors are intended to maximize expected return, subject to a downside risk 
constraint. Similarly, portfolio theory predicts the existence of investors with 
quadratic preferences, who care only about the mean and variance of returns, 
and not about extreme losses (Levy and Markowitz 1979). The empirical 
literature shows that at times people’s choices are consistent with Roy’s 
framework, and at other times people’s choices are consistent with Markowitz’s 
framework. As such, the present study advances the literature by showing that: 
1) biological correlates to Roy’s and Markowitz’s frameworks do exist—namely, 
safety-first investors have low levels of stress, whereas mean-variance investors 
possess high levels of stress, and 2) stress levels influence whether investors 
follow Roy’s or Markowitz’s framework of decision making.  
 Finally, the results in Table 4.2 show that Sal-CO has a unique (inverted 
U-shape) relation to portfolio abnormal return. That is, subjects with intermediate 
levels of stress achieve greater abnormal return than subjects with high or low 
levels of stress. Since both the Sharpe ratio and the portfolio abnormal return are 
risk-adjusted performance measures, one would expect them to possess a 
similar relation to stress levels. However, unlike the Sharpe ratio, abnormal 
return captures skewness and other higher-order moments of the return 
distribution (Leland 2002). In fact, the finance literature shows that investors do 
value higher-order moments (Kraus and Litzenberger 1976). Therefore, the 
results in Table 4.2 show that stress levels influence the value that investors 
place on higher-order moments of the return distribution. In particular, subjects 
with intermediate stress levels assign a greater value to positive skewness, 
94 
achieving greater abnormal return than subjects with high and low stress levels. 
These results are congruent with performance maximization under moderate 
levels of stress, as predicted by the Yerkes–Dodson hypothesis. Furthermore, 
the results are supported by medical studies showing that variance and 
skewness are processed by two different brain areas, both of which are known 
targets of cortisol (Symmonds et al. 2011).  
4.4.3. Stress and Options Trading Performance 
 Trading in options is generally more demanding than stock trading, or 
even futures trading.43 Therefore, options trading is a superior way to study the 
effect of stress on trading choices and outcomes. Table 4.3 displays the relation 
between Sal-CO and different trading choices available to subjects during the 
options-trading task. The results show that stress exerts a significant influence on 
trading choices, including the number of orders submitted, order type (i.e., limit 
versus market orders), trading position (i.e., selling versus buying), and trading 
time preferences. Lakonishok et al. (2007) shows that options trading is largely 
motivated by speculation on the direction of future stock price movements. As 
such, it is not surprising that the relation between stress and trading choices is 
significant at the contract level, and not at the portfolio level. In other words, by 
focusing on individual options subjects can speculate based on the risk profile of 
the different contracts.  
 The results in Table 4.3 create several important conclusions. First, stress 
exerts a more direct influence on selling decisions than buying decisions. Indeed, 
                                                            
43 This is because option contracts are more difficult to understand, have more alternatives, and 
possess more leverage and positive payout skewness. 
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selling is more stressful than buying, since even experienced traders have a hard 
time exiting losing trades (Odean 1998). Furthermore, medical studies show that 
the amygdala, which plays a central role in the stress response, is activated 
during selling decisions (of an owned asset), but not during buying decisions 
(Weber et al. 2007).  
 Second, the influence of stress on risk preferences is different for 
“optimists” and “pessimists.”44 This result is consistent with the Transactional 
Model of Stress, which emphasizes the importance of the appraisal process in 
the stress response (Lazarus and Folkman 1984). Table 4.3 shows that high-
stress optimists preferentially sell 25P, whereas low-stress optimists 
preferentially sell 24P. The at-the-money 25P is riskier than the out-of-the-money 
24P, due to the higher delta of the former. Therefore, the results show optimists 
with high stress levels take more risk than optimists with low stress levels. 
Additionally, Table 4.3 shows that high-stress pessimists sell more of the 26C, 
whereas low-stress pessimists sell less of the 26C. Selling a naked call, as is the 
case when one sells 26C, is the riskiest alternative in options trading, because 
the potential losses are boundless. The associated results show that pessimists 
with high levels of stress take less (extreme) risk than pessimists with low levels 
of stress.  
 Third, the results show that stress possesses a U-shaped relation to order 
type (i.e., limit versus market orders) and to timing preferences. Specifically, 
                                                            
44 In the present study, “optimists” are identified as having a positive outlook about the future 
stock price, and their trading is characterized by buying call options and/or selling put options. 
Alternatively, pessimists are identified as having a negative outlook about the future stock price, 
and their trading is characterized by buying put options and/or selling call options.  
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subjects with high or low levels of stress submit a greater proportion of 26C limit 
orders, begin trading earlier, and spend more time trading than subjects with 
intermediate levels of stress. Since 26C is the contract with the highest price, 
using limit orders can result in preferred transactions for high and low stress 
subjects. Furthermore, the fact that high and low stress subjects spend more 
total time trading (i.e., the time elapsed from first to last order submission) 
provides them with more opportunities to perform favorable trades. In fact, the 
performance results in Table 4.4 show that subjects with high or low stress levels 
have better 25C risk-adjusted performance than subjects with intermediate levels 
of stress. In terms of gross return (P&L), subjects with low levels of stress 
achieve superior 24P performance. These results are opposite of what the 
Yerkes–Dodson hypothesis predicts about the stress-performance relation, 
showing that trading performance is not always optimal at moderate levels of 
stress.  
4.5. Conclusions 
 Financial decisions often are perceived as being stressful. At times, they 
can invoke powerful emotional and cognitive processes that curb reason and 
performance. As such, it is critical to understand the role of stress on the 
decision-making process. This study provides one of the first comprehensive 
analyses of the relation between stress levels and financial choices under 
investing and trading frameworks. The tasks are realistic, and the measure of 
stress is unbiased. The results have important implications both for academic 
research and for financial decision making.   
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 The literature (described in Section 4.2) does not agree on the direction of 
the relation between stress and risk preferences during financial decision 
making. Some studies show that stress exhibits a positive correlation with risk 
aversion, whereas other studies show that stress has a positive correlation with 
risk taking. However, such incongruences reflect the very nature of stress as an 
adaptation mechanism. If all stress responses were equal, then there could be no 
adapting to new situations. Therefore, prior studies are simply capturing the 
proper stress response under the given circumstances.  
  The present study shows that the stress response is significantly different 
between investing and trading tasks. Furthermore, stress has a different relation 
to initial and subsequent investment choices. Specifically, stress has a significant 
positive linear relation to risk-aversion during initial investment decisions. 
Consequently, portfolios of high stress subjects are less risky and profitable than 
portfolios of low stress subjects. Alternatively, the relation of stress to subsequent 
investment decisions is greatly diminished by subjects’ memory of their initial 
investment performance. Hence, stress is not significantly related to the 
performance of rebalanced portfolios. These results could be generalized to the 
population of naïve investors. However, the results might be different in a sample 
of professional investors for two main reasons: First, professional investors are 
less likely than naïve investors to allow their past performance to play a major 
role on their investment decisions. Second, professional investors make risky 
investment choices despite their overwhelming levels of stress. Therefore, future 
studies could examine the relation of stress and financial decision-making in 
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professional investors. Regarding trading decisions, the results show that stress 
plays a pervasive role in many aspects of trading choices. One of the most 
interesting results is the modulating role of the stress appraisal process on the 
relation between stress and risk-taking. That is, the influence of stress during 
trading decisions is different for optimists and pessimists. Specifically, high stress 
optimists take more risk than low stress optimists, whereas high stress 
pessimists take less risk than low stress pessimists. Whether or not these results 
could be generalized to professional investors needs further research. However, 
modern psychology theory predicts that the stress appraisal process is an 
important modulator of the stress response. Therefore, professional investors 
might not be different from naïve investors in this regard.  
 Finally, this study could be expanded in several ways in order to address 
some important related questions. First and foremost, the present study is 
primarily a correlational study. Therefore, conclusions regarding the direction of 
the relation between stress and financial decisions and outcomes must be drawn 
with care. Future studies could address causality more appropriately via cortisol 
administration. Second, stress might work in conjunction with other endogenous 
factors, such as testosterone and personality traits, to exert an influence on 
financial decision-making. Future studies could address these factors together 
rather than separately. Third, given the almost universal focus on investment 
biases in the current behavioral finance literature, future studies could address 
the relation between stress and investment biases. Finally, this study stops at the 
level of the individual investor. Future studies could address the relation between 
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stress and market behavior. Overall, it is my hope that the present study 
encourages other researchers to explore this new and exciting area of behavioral 
finance.  
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Table 4.1 
Stress and Asset Allocation 
The table displays the coefficients for three regression models, where the 
proportion of funds allocated to the exchange-trade fund (ETF) securities 
(HOME, GROW, BOND, MINE, and MMKT) or not invested (CASH) is the 
dependent variable. An ETF is an investment fund traded on stock exchanges 
like a single stock. ETFs are composed of many assets, including stocks, 
commodities, and bonds. In addition to the five ETFs and CASH, the table 
displays the combined proportion of funds invested in low-risk securities (MMKT 
and CASH) and high-risk securities (HOME and GROW). An additional, fourth 
model is performed on DIV2 variables to control for the level of performance 
during DIV1. Only the significant results are displayed in this table, and all 
subsequent tables. See the text for clarification. 
 
Panel A: DIV1 
 Model Linear Sal-CO Quadr. Sal-CO Gender Regression R2
CASH 1 *82.15  0.08
LOW RISK 1 *73.32  0.07
HIGH RISK 1 *-57.73  0.07
 2 *-74.89 14.23  0.08
 3 *-72.87 13.55 *127.75 0.16
 
Panel B: DIV2 
 Model Linear 
Sal-CO
Quadratic 
Sal-CO
Gender DIV1 NLV Regression 
R2
MMKT 2 -15.03 *18.25  0.09
 3 -15.03 *18.25 -2.30  0.09
 4 -17.70 *18.67 -0.14 -8.79 0.10
Notes: The explanatory variables are given by the model as follows: 
Model 1 has salivary cortisol (Sal-CO) as the single explanatory variable. 
Model 2 introduces a quadratic term. 
Model 3 introduces a dummy variable for gender (Female=0, Male=1). 
Model 4 (DIV2 only) introduces the standardized Net Liquidation Value (NLV) of 
DIV1 to control for DIV1 performance.  
Sample regression R2 is displayed in the last column. 
Regression coefficients are multiplied by 1,000 to show them more clearly. 
Significance is displayed at the 10% (*), 5% (**) and 1% (***) levels. 
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Table 4.2 
Relation of Stress to Expected Portfolio Performance  
The table displays the coefficients for three regression models, where the 
dependent variable is a measure of expected portfolio performance during DIV1. 
There were no significant results for DIV2. Monte Carlo simulations of 2,000 
iterations are performed for each subject, based on their asset allocation choices 
and the return distribution of the assets, in order to measure expected portfolio 
performance. These measures are: expected annual return, expected annual 
volatility of returns, expected Sharpe ratio, percent shortfall, expected abnormal 
return, and the 5% value at risk (VaR).  
 Model Linear Sal-CO Quadr. Sal-CO Gender Regression R2
Return 1 **-8.04  0.11
Volatility 1 *-12.81  0.08
Sharpe ratio 1 *42.28  0.08
Shortfall 1 **59.56  0.11
 2 *62.71 -2.62  0.11
 3 *61.67 -2.27 -66.34 0.14
VaR 1 *13.95  0.07
Abn. Return 2 0.88 **-1.50  0.12
 3 0.82 **-1.48 *-3.76 0.19
Notes: The explanatory variables are given by the model as such: 
Model 1 has salivary cortisol (Sal-CO) as the single explanatory variable. 
Model 2 introduces a quadratic term. 
Model 3 introduces a dummy variable for gender (Female=0, Male=1). 
Sample regression R2 is displayed in the last column. 
Regression coefficients are multiplied by 1,000 to show them more clearly. 
Significance is displayed at the 10% (*), 5% (**) and 1% (***) levels. 
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Table 4.3 
Cortisol and Options Trading Preferences 
The table displays the coefficients for three regression models, where the 
dependent variable is a measure of trading preferences for different options 
contracts. These measures are, from top to bottom in the first column: the 
proportion of orders submitted, the proportion of limit orders (Limit), the 
proportion of sell orders, the number of seconds elapsed before the first order is 
submitted, and the total trading time.  
 Model Linear Sal-CO Quadr. Sal-CO Gender Regression R2
25P Orders 1 *51.98  0.08
 2 *71.95 -17.39  0.09
 3 *71.76 -17.22 -40.27 0.10
26C Limit  2 **-69.60 **41.92  0.13
 3 **-69.15 **41.53 *95.13 0.20
24P Sells 1 **-27.08  0.09
 2 *-33.90 5.94  0.10
 3 *-34.06 6.08 -33.13 0.13
25P Sells 1 *24.98  0.07
26C Sells 2 **-47.43 17.31  0.11
 3 **-47.16 17.07 56.86 0.17
First Order 2 **22.36 **-11.07  0.16
 3 **22.44 **-11.13 15.18 0.19
Trading Time 2 *-21.43 *11.99  0.10
 3 *-21.50 *12.04 -13.33 0.11
Notes: The explanatory variables are given by the model as follows: 
Model 1 has salivary cortisol (Sal-CO) as the single explanatory variable. 
Model 2 introduces a quadratic term. 
Model 3 introduces a dummy variable for gender (Female=0, Male=1). 
Sample regression R2 is displayed in the last column. 
Regression coefficients are multiplied by 1,000 to show them more clearly. 
Significance is displayed at the 10% (*), 5% (**) and 1% (***) levels. 
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Table 4.4 
Cortisol and Trading Performance 
The table displays the coefficients for three regression models, where the 
dependent variables are the final profit and loss value (P&L), and the ratio of 
average to standard deviation of Net Liquidity Value (coefficient of variation, CV).  
 Model Linear Sal-CO Quadr. Sal-CO Gender Regression R2
P&L 24P 1 **-2314  0.11
CV 25C 2 -0.26 *0.15  0.08
 3 -0.26 *0.16 -0.38 0.13
Notes: The explanatory variables are given by the model as follows: 
Model 1 has salivary cortisol (Sal-CO) as the single explanatory variable. 
Model 2 introduces a quadratic term. 
Model 3 introduces a dummy variable for gender (Female=0, Male=1). 
Sample regression R2 is displayed in the last column. 
Regression coefficients are multiplied by 1,000 to show them more clearly. 
Significance is displayed at the 10% (*), 5% (**) and 1% (***) levels. 
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APPENDICES 
 
Appendix A: Descriptions of Investment Measures 
 
Portfolio diversification (PDIV): The coefficient of determination (R-squared) of 
the linear regression between portfolio excess returns (the dependent variable) 
and market excess returns (the independent variable).45   
Average return (AVE): The annualized arithmetic mean of the portfolio excess 
returns.  
Holding period return (HPR): The annualized geometric mean of the portfolio 
excess returns.  
Return volatility (SD): The annualized standard deviation of portfolio excess 
returns. In order to annualize the volatility, the weekly standard deviation is 
multiplied by the square root of 52. 
Sharpe ratio: The annualized arithmetic mean of portfolio excess returns divided 
by the annualized standard deviation of portfolio excess returns.46 
Alpha: The intercept of the linear regression between portfolio excess returns 
and the market excess returns. As with the other measures of portfolio return, 
alpha is annualized.  
                                                            
45 In all the calculations, the three-month Treasury bill rate is used as a proxy for the risk-free rate 
of return, whereas the Standard & Poor’s 500 index (S&P500) is used as a proxy for the market 
rate of return. 
 
46 When ranking portfolios by the Sharpe or Treynor ratios it is necessary to make an adjustment 
to the traditional formulas when portfolios with negative average excess returns exist. For 
instance, suppose that we want to rank two portfolios with equal positive average excess returns; 
the one with the lowest return volatility (standard deviation) receives a higher Sharpe ratio. On the 
other hand, if the portfolios possess equal negative average excess returns, then the one with the 
highest volatility receives a higher (less negative) Sharpe ratio, a counterintuitive result. A way to 
correct this issue is to make an adjustment to the traditional Sharpe ratio formula by adding an 
exponent to the denominator. The exponent is excess return divided by the absolute value of the 
excess return. A similar adjustment is necessary for the traditional Treynor ratio formula. 
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Beta: The slope of the linear regression between portfolio excess returns and 
market excess returns.  
Treynor ratio: The annualized arithmetic mean of portfolio excess returns divided 
by the portfolio beta. When excess returns are negative, the Treynor ratio is 
modified in a similar fashion as the Sharpe ratio.  
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Appendix B: Abnormal Factor Score Descriptions 
 
Low Score Description Factor High Score Description 
Is happy, mind works well, does not find 
ill health frightening 
(Low hypochondriasis) 
D1 
Shows overconcern with bodily functions, 
health, or disabilities 
(High hypochondriasis) 
Is contented about life and 
surroundings, has no death wishes 
(Zestfulness) 
D2 
Is disgusted with life, harbors thoughts or 
acts of self-destruction 
(Suicidal disgust) 
Avoids dangerous and adventurous 
undertakings, has little need for 
excitement 
(Low brooding discontent) 
D3 
Seeks excitement, is restless, takes risks, 
tries new things 
(High brooding discontent) 
Is calm in emergency, confident about 
surroundings, poised 
(Low anxious depression) 
D4 
Has disturbing dreams, is clumsy in 
handling things, tense, easily upset 
(High anxious depression) 
Shows enthusiasm for work, is 
energetic, sleeps soundly 
(High energy euphoria) 
D5 
Has feelings of weariness, worries, lacks 
energy to cope 
(Low energy depression) 
Is not troubled by guilt feelings, can 
sleep no matter what is left undone 
(Low guilt and resentment) D6 
Has feelings of guilt, blames self for 
everything that goes wrong, is critical of 
self 
(High guilt and resentment) 
Is relaxed, considerate, cheerful with 
people 
(Low bored withdrawal) 
D7 
Avoids interpersonal contact, shows 
discomfort with people 
(High bored withdrawal) 
Is trusting, not bothered by jealousy or 
envy 
(Low paranoia) 
Pa 
Believes he is being persecuted, spied on, 
poisoned, controlled, mistreated 
(High paranoia) 
Avoids engagement in illegal acts or 
breaking rules, sensitive 
(Low psychopathic deviation) 
Pp 
Complacent towards own or others, anti-
social behavior, is not hurt by criticism 
(High psychopathic deviation) 
Realistically appraises himself and 
others, shows absence of regressive 
behavior 
(Low schizophrenia) 
Sc 
Retreats from reality, has uncontrolled and 
sudden impulses 
(High schizophrenia) 
Is not bothered by unwelcome thoughts 
and ideas or compulsive habits 
(Low psychasthenia) 
As 
Suffers insistent, repetitive ideas and 
compulsive habits 
(High psychasthenia) 
Considers himself as good, 
dependable, and smart as most others 
(Low general psychosis) 
Ps 
Has feelings of inferiority and 
unworthiness, timid, loses head easily 
(High general psychosis) 
Notes: This table describes the twelve abnormal personality factors measured in 
Part II of Cattell’s Clinical Analysis Questionnaire. The “Low Score Description” 
pertains to sten scores between 1 and 3, whereas the “High Score Description” 
pertains to sten scores between 8 and 10. Each description is followed by its 
clinical name shown in parenthesis. The lower the sten score, the greater the low 
score description applies to the individual. Similarly, the higher the sten score, 
the greater the high score description applies. This table is from the Manual for 
the Clinical Analysis Questionnaire.  
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Appendix C: Portfolio Efficiency 
 
 The appendix figure shows the efficient frontiers and the individual 
portfolios formed during DIV1 (Panel A) and DIV2 (Panel B). The figures show 
that portfolios are more clustered together in DIV2 than in DIV1. This is 
consistent with the results provided in Table 3.1 (Chapter 3), which shows that 
portfolio return and volatility have lower standard deviations in DIV2. Thus, the 
figure supports the notion that the performance during DIV1 influenced the 
allocation choices during DIV2. The figure also shows that DIV2 portfolios lie 
closer to the efficient frontier than DIV1 portfolios. To test this notion, it is 
necessary to measure the distance between each portfolio and the efficient 
frontier.  
Since investors could choose not to invest a portion of their allowance 
(CASH), their position is equivalent to having the choice to allocate their funds 
between the market portfolio (the efficient portfolio with highest Sharpe ratio) and 
a risk-free asset that pays zero return. As such, the “new” efficient frontier is the 
tangency line that connects the risk-free rate to the market portfolio (also known 
as the Capital Allocation Line (CAL)), together with the portion of the Markowitz 
efficient set of risky assets above the market portfolio 
For a given level of return, modern portfolio theory predicts that the 
variance of a portfolio on the efficient frontier, excluding CAL, is a product of its 
expected return (E(Rp)), the vector of asset returns (µ), and the matrix of 
covariances between the risky assets (V), as shown in Equation 1: 
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Equation 1 can be employed to compute coordinate points on the efficient 
frontier above the tangency portfolio. Similarly, the equation for CAL (Equation 2) 
can be used to compute the coordinate points on the efficient frontier below the 
tangency portfolio. The CAL equation is a linear formula that relates the expected 
portfolio return and volatility (σp) to the expected return and volatility of the 
market portfolio (shown with subscript “M”), and the risk-free rate (which is zero 
in this case) 
   M fp f p
M
E R r
E R r  
      (2) 
Together, Equations 1 and 2 can be used to calculate the horizontal distance 
between each portfolio and the efficient frontier — that is, the difference between 
the realized portfolio volatility, and the volatility of the efficient portfolio of equal 
expected return.  
 The appendix figure shows that four portfolios in DIV1 (Panel A) and one 
portfolio in DIV2 (Panel B) fall below the expected return of the tangency portfolio 
(two portfolios overlap in DIV1). For these five portfolios, Equation 2 is used to 
calculate the horizontal distance to the efficient frontier, whereas Equation 1 is 
used for the remaining portfolios. The average horizontal distance to the efficient 
frontier of DIV1 portfolios is 1.91% (SD=1.17%), whereas the average horizontal 
distance to the efficient frontier of DIV2 portfolios is 1.69% (SD=0.93%). 
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Nevertheless, this difference is not statistically significant, showing that portfolio 
efficiency is similar for both tasks.  
Appendix C Figure 
The Efficient Frontier and DIV1 and DIV2 Portfolios 
The curves displayed in red represent the efficient frontiers in the absence of a 
risk-free rate instrument. Since investors could potentially leave a portion of their 
funds uninvested (in Cash), it is equivalent to having the option of investing in a 
risk-free asset with a return of zero. The efficient frontier then becomes the 
tangency line, displayed in black, plus the upper portion of the red curve. The 
dots displayed in blue represent the individual investor portfolios. 
  
Panel A:  DIV1 Portfolios 
 
Panel B: DIV2 Portfolios 
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